Vislink (VISL) 10-Q 27 May 20 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2020	May 27, 2020
Document And Entity Information
Entity Registrant Name	Vislink Technologies, Inc.
Entity Central Index Key	0001565228
Document Type	10-Q
Document Period End Date	Mar. 31, 2020
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business Flag	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		88,276,562
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2020

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Current assets
Cash	$ 2,459,000	$ 1,737,000
Accounts receivable, net	3,988,000	6,714,000
Inventories, net	8,374,000	7,674,000
Prepaid expenses and other current assets	662,000	660,000
Total current assets	15,483,000	16,785,000
Right of use assets, operating leases	1,782,000	1,925,000
Property and equipment, net	1,888,000	1,972,000
Intangible assets, net	2,621,000	2,922,000
Total assets	21,774,000	23,604,000
Current liabilities
Accounts payable	4,390,000	6,784,000
Accrued expenses	2,449,000	1,912,000
Notes payable	293,000	339,000
Operating lease obligations, current	383,000	821,000
Due to related parties		505,000
Customer deposits and deferred revenue	2,137,000	2,821,000
Derivative liabilities	13,000	30,000
Total current liabilities	9,665,000	13,212,000
Operating lease obligations, net of current portion	1,332,000	1,163,000
Total liabilities	10,997,000	14,375,000
Commitments and contingencies (See Note 9)
Stockholders' equity
Preferred stock - $0.00001 par value per share: 10,000,000 shares authorized as of March 31, 2020, and December 31, 2019; 0 shares issued and outstanding as of March 31, 2020, and December 31, 2019
Common stock - $0.00001 par value per share, 100,000,000 shares authorized, 81,100,685 and 21,567,287 shares issued and 81,084,731 and 21,551,333 outstanding as of March 31, 2020 and December 31, 2019, respectively
Additional paid in capital	267,572,000	261,871,000
Accumulated other comprehensive income	484,000	207,000
Treasury stock, at cost - 15,954 shares at March 31, 2020, and December 31, 2019, respectively	(277,000)	(277,000)
Accumulated deficit	(257,002,000)	(252,572,000)
Total stockholders' equity	10,777,000	9,229,000
Total liabilities and stockholders' equity	$ 21,774,000	$ 23,604,000

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.00001	$ 0.00001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued		21,567,287
Common Stock, shares, outstanding	81,084,731	21,551,333
Treasury stock, shares	15,954	15,954

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Revenue, net	$ 5,352,000	$ 8,206,000
Cost of revenue and operating expenses
Cost of components and personnel	2,821,000	4,127,000
Inventory valuation adjustments	25,000	47,000
General and administrative expenses	6,200,000	5,183,000
Gain on lease termination	(21,000)
Research and development expenses	656,000	926,000
Amortization and depreciation	423,000	589,000
Total cost of revenue and operating expenses	10,104,000	10,872,000
Loss from operations	(4,752,000)	(2,666,000)
Other (expense) income
Changes in fair value of derivative liabilities	17,000	(74,000)
Gain on settlement of related party obligation	331,000
Interest expense	(26,000)	(350,000)
Total other (expense) income	322,000	(424,000)
Net (loss) income	$ (4,430,000)	$ (3,090,000)
Basic and diluted loss per share	$ (0.09)	$ (1.62)
Weighted average number of shares outstanding:
Basic and diluted	48,696,000	1,906,000
Comprehensive loss:
Net loss	$ (4,430,000)	$ (3,090,000)
Unrealized gain (loss) on currency translation adjustment	277,000	(33,000)
Comprehensive loss	$ (4,153,000)	$ (3,123,000)

Consolidated Statement of Chang

Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Preferred Stock [Member]	Common Stock [Member]	Additional Paid In Capital [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Income [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2018			$ 244,562	$ (22)	$ 275	$ (234,525)	$ 10,290
Balance, shares at Dec. 31, 2018		1,877,698
Net loss						(3,090)	(3,090)
Unrealized gain (loss) on currency translation adjustment					(33)		(33)
Issuance of common stock in connection with: Payments made in stock (payroll and consultants)			66				66
Issuance of common stock in connection with: Payments made in stock (payroll and consultants), shares		17,984
Issuance of common stock in connection with: Compensation awards previously accrued			71				71
Issuance of common stock in connection with: Compensation awards previously accrued, shares		19,631
Issuance of common stock in connection with: Conversion of amounts due to related parties			30				30
Issuance of common stock in connection with: Conversion of amounts due to related parties, shares		8,159
Stock-based compensation			609				609
Balance at Mar. 31, 2019			245,338	(22)	242	(237,615)	7,943
Balance, shares at Mar. 31, 2019		1,923,472
Balance at Dec. 31, 2019			261,871	(277)	207	(252,572)	9,229
Balance, shares at Dec. 31, 2019		21,567,287
Net loss						(4,430)	(4,430)
Unrealized gain (loss) on currency translation adjustment					277		277
Stock-based compensation			405				405
Issuance of common stock in connection with: Underwriting equity raises, net of offering costs			5,286				5,286
Issuance of common stock in connection with: Underwriting equity raises, net of offering costs, shares		12,445,000
Issuance of common stock in connection with: Exercise of common stock warrants			10				10
Issuance of common stock in connection with: Exercise of common stock warrants, shares		22,970,300
Issuance of common stock in connection with: Exercise of cashless common stock warrants
Issuance of common stock in connection with: Exercise of cashless common stock warrants, shares		24,118,098
Balance at Mar. 31, 2020			$ 267,572	$ (277)	$ 484	$ (257,002)	$ 10,777
Balance, shares at Mar. 31, 2020		81,100,685

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows used in operating activities
Net loss	$ (4,430)	$ (3,090)
Adjustments to reconcile net loss to net cash used in operating activities
Gain on lease termination	(21)
Gain on settlement of related party obligations	(331)
Stock-based compensation	405	609
Payment made in stock (payroll and consultants)		66
Stock issuance commitments		45
Provision for bad debt	12
Inventory valuation adjustments	25	47
Amortization of right of use assets, operating assets	156	50
Depreciation and amortization	423	589
Change in fair value of derivative liabilities	(17)	74
Amortization of debt discount		22
Changes in assets and liabilities
Accounts receivable	2,568	738
Inventory	(1,012)	458
Prepaid expenses and other current assets	(30)	(84)
Accounts payable	(1,732)	(1,297)
Accrued expenses and interest expense	604	336
Operating lease liabilities	(261)
Deferred revenue and customer deposits	(620)	(72)
Due to related parties	(174)	(55)
Net cash used in operating activities	(4,435)	(1,564)
Cash flows used in investing activities
Cash used in for property and equipment	(97)	(39)
Net cash used in investing activities	(97)	(39)
Cash flows provided (used) in financing activities
Proceeds received from equity financings	5,998
Costs incurred in connection with equity financing	(712)
Proceeds from the exercise of common stock warrants	10
Principal payments in connection with working capital financing note	(46)
Principal payments made on convertible promissory notes		(85)
Net cash provided (used) in financing activities	5,250	(85)
Effect of exchange rate changes on cash	4	7
Net increase (decrease) in cash	722	(1,681)
Cash, beginning of period	1,737	2,005
Cash, end of period	2,459	324
Supplemental disclosure of cash flow information:
Cash paid during the period for interest	16	8
Cash paid during the period for income taxes
Supplemental disclosure of non-cash information:
Common stock issued in connection with: services previously accrued		71
Common stock issued in connection with: Settlement of amounts due to related parties		30
ROU assets and operating lease obligations recognized (Note 4):
Operating lease assets recognized	546	2,899
less: non-cash changes to operating lease assets amortization	(156)
less: non-cash changes to operating lease assets lease termination	(533)
Total non-cash disclosures of ROU assets	(143)	2,899
Operating lease liabilities recognized	546	2,955
Less: non-cash changes to operating lease liabilities
Less: non-cash changes to operating lease liabilities amortization	(261)
Less: non-cash changes to operating lease liabilities lease termination	(533)
Total non-cash disclosures operating lease obligations	$ (268)	$ 2,955

Organization and Summary of Sig

Organization and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Summary of Significant Accounting Policies	NOTE 1 — ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Description of Business The overarching strategy of Vislink Technologies, Inc. (“Vislink Technologies,” the “Company,” “we,” “our” or “us”) is to design, develop and deliver advanced wireless communications solutions that provide customers within target markets with enhanced levels of reliability, mobility, performance and efficiency in their business operations and missions. Vislink Technologies’ business lines include the leading brands Integrated Microwave Technologies LLC (“IMT”) and Vislink Communications Systems (“Vislink” or “VCS”). There is considerable brand interaction, due to complementary market focus, compatible product, and technology development roadmaps, and solution integration opportunities. IMT: The IMT business develops, manufactures, and sells microwave communications equipment utilizing COFDM (Coded Orthogonal Frequency Division Multiplexing) technology. COFDM is a transmission technique that combines encoding technology with OFDM (Orthogonal Frequency Division Multiplexing) modulation to provide the low latency and high image clarity required for real-time live broadcasting video transmissions. IMT has extensive experience in ultra-compact COFDM wireless technology, which has allowed IMT to develop integrated solutions over the past 20 years that deliver reliable video footage captured from both aerial and ground-based sources to fixed and mobile receivers’ locations. IMT provides product and service solutions marketed under the well-established brand names Nucomm, RF Central, and IMT. Its video transmission products primarily address three major market areas: broadcasting, sports and entertainment, and surveillance (for military and government). Vislink: Vislink specializes in the wireless capture, delivery, and management of secure, high-quality, live video from the field to the point of usage. Vislink designs and manufactures products encompassing microwave radio components, satellite communication, cellular and wireless camera systems, and associated amplifier items. Vislink serves two core markets: (i) broadcast and media and (ii) law enforcement, and surveillance. In the broadcast and media market, Vislink provides broadcast communication links for the collection of live news and sports and entertainment events. Customers in this market include national broadcasters, multi-channel broadcasters, network owners and station groups, sports and live broadcasters, and hosted service providers. In the law enforcement and surveillance market, Vislink provides secure video communications and mission-critical solutions for law enforcement, defense, and homeland security applications. Its law enforcement and surveillance customers include metropolitan, regional, and national law enforcement agencies, as well as domestic and international defense agencies and organizations. Basis of Presentation The accompanying unaudited condensed consolidated financial statements are prepared under the United States generally accepted accounting principles (“US GAAP”) for interim financial information and following the instructions to Form 10-Q and Regulation S-X. Accordingly, these financial statements do not include all information or notes required by GAAP for annual financial statements. They should be read in conjunction with the consolidated financial statements as filed on the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, filed with the United States Securities and Exchange Commission (the “SEC”) on April 1, 2020. In the opinion of management, the unaudited condensed consolidated financial statements included herein contain all adjustments necessary to present fairly the Company’s consolidated financial position as of March 31, 2020, the results of its operations and cash flows for the three months ended March 31, 2020, and 2019. Such adjustments are of a normal recurring nature. The results of operations for the three months ended March 31, 2020, may not be indicative of results for a full year, any other interim period or any future year period. Principles of Consolidation The accompanying financial statements have been prepared in conformity with US GAAP as found in the Accounting Standards Codification (“ASC”), the Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”) and the rules and regulations of the SEC. The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, IMT and Vislink. All intercompany accounts and transactions among consolidated entities were eliminated upon consolidation. Use of Estimates The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company’s consolidated financial statements include the useful lives of property, plant, and equipment, impairment of long-lived assets, allowance for accounts receivable doubtful accounts, allowance for inventory obsolescence reserve, allowance for deferred tax assets, valuation of warranty reserves, contingent consideration liabilities, and the accrual of potential liabilities. Actual results could differ from these estimates. There have been no new or material changes to the accounting estimates discussed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019, that are of significance, or potential significance, to the Company. Risks and Uncertainties We are subject to risks and uncertainties as a result of the COVID-19 pandemic. The extent of the impact of this pandemic on the Company’s business is highly uncertain and difficult to predict, as the response to this plight may still be in its emerging stages, and information is rapidly evolving. The capital markets and economies worldwide experienced inopportune circumstances from the COVID-19 pandemic, and such adverse events may cause a local or global economic recession. Any economic disruption could have a disadvantageous material effect on our business and reduce our capital resources and access to capital, with possible unfavorable implications on our financial condition and results of operations. Policymakers around the globe have responded with fiscal policy actions to support their industries and economies, but the magnitude and overall effectiveness of these interventions remain uncertain. The severity of the COVID-19 pandemic’s impact on the Company’s business depends on several factors, including the pandemic’s duration and effect on the Company’s customers, which cannot be predicted at this time. There may also be an adverse impact on the Company’s future results of operation and liquidity, and the Company may experience delays in payments of outstanding accounts receivable, supply chain disruptions, and weakening demand. It is uncertain to what extent the COVID-19 pandemic may materially impact the Company’s financial condition, amongst any initiatives or programs that the Company may undertake, if any, as of the date of the issuance of these unaudited condensed consolidated financial statements. The Company can give no assurance that a material impact on the Company’s financial condition has not resulted or will not result in the future. Inventories The Company records inventory at the lower of cost, on a first-in, first-out basis, or net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Inventory valuation adjustments are on the face of the unaudited condensed consolidated statements of operations for the three months ended March 31, 2020, and 2019. Revenue Recognition We account for the Company’s operating results under ASC Topic 606 adopted on January 1, 2019. It is a comprehensive revenue recognition model that requires revenue to be recognized when the Company transfers control of the promised goods or services to our customers at an amount that reflects the consideration that we expect to receive. The application of ASC Topic 606 requires us to use more judgment and make more estimates than under previously issued guidance. The Company generates all its revenue from contracts with customers. The Company recognizes revenue when we satisfy a performance obligation by transferring control of the promised goods or services to a customer in an amount that reflects the consideration that we expect to receive in exchange for those services. The Company determines revenue recognition through the following steps: 1. Identification of the contract, or contracts, with a customer; 2. Identification of the performance obligations in the contract; 3. Determination of the transaction price; 4. Allocation of the transaction price to the performance obligations in the contract; and 5. Recognition of revenue, when, or as, we satisfy a performance obligation. At contract inception, the Company assesses the goods and services promised in our contracts with customers and identifies a performance obligation for each. To determine the performance obligations, the Company considers all the products and services promised in the contract regardless of whether they are explicitly stated or implied by customary business practices. The timing of satisfaction of the performance obligation is not subject to significant judgment. We measure revenue as the amount of consideration we expect to receive in exchange for transferring goods and services. Excluded from income are the value-added sales taxes, and other charges we collect concurrent with revenue-producing activities. Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less. Leases We determine if an arrangement is a lease at inception. We recognize lease expense for lease payments on a straight-line basis over the lease term. The Company includes operating leases as ROU assets as “Right of use assets, operating leases” in the consolidated balance sheets. For lease liabilities, operating lease liabilities are included in “Operating lease obligations, current” and “Operating lease liabilities, net of current portion,” in the consolidated balance sheets. We recognize Operating lease ROU assets and liabilities on the commencement date based on the present value of lease payments for all leases with a term longer than 12 months. There is no separation of lease and non-lease components for all our contracts of real estate. The ROU. asset and related lease liabilities recorded under ASC 842 are calculated based on the present value of the lease payments using (1) the rate implicit in the lease or (2) the lessee’s incremental borrowing rate (“IBR”), defined as the rate of interest that a lessee would have to pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a comparable economic environment. As most of our leases do not provide an implicit rate, we generally use our incremental borrowing rates based on an analysis of prior collateralized borrowings over similar terms of the lease payments at the commencement date, to estimate the IBR under ASC 842. There were no capital leases, which are now titled “finance leases” under ASC 842, in the Company’s lease portfolio as of March 31, 2020. Stock-Based Compensation The Company accounts for stock compensation with persons classified as employees for accounting purposes following ASC 718 “Compensation – Stock Compensation,” which recognizes awards at fair value on the date of grant and recognition of compensation over the service period for awards expected to vest. The fair value of stock options is determined using the Black-Scholes Option Pricing Model. The fair value of common stock issued for services is determined based on the Company’s stock price on the date of issuance. Under ASU 2018-07, the scope of Topic 718 was expanded to include share-based payment transactions for acquiring goods and services from non-employees. Equity-classified non-employee share-based payment awards are no longer measured at the earlier of the date at which a commitment for performance by the counterparty is reached or the date at which the counterparty’s performance is complete. Instead, they are now measured at the grant date. Non-employee share-based payment awards with performance conditions are measured at the lowest aggregate fair value under today’s guidance, which often results in zero value. ASU 718 aligns the accounting for non-employee share-based payment awards with performance conditions with accounting for employee share-based payment awards under Topic 718 by requiring entities to consider the probability of satisfying performance conditions. Current guidance requires entities to use the contractual term for the measurement of the non-employee share-based payment awards. ASU 718 allows entities to make an award-by-award election to use either the expected term (consistent with employee share-based payment awards) or the contractual term for non-employee awards Loss Per Share The Company reports a loss per share under ASC Topic 260, “Earnings Per Share,” which establishes standards for computing and presenting earnings per share. The calculation of basic loss per share of common stock divides the net loss allocable to common stockholders by the weighted-average shares of common stock outstanding during the period, without consideration of common stock equivalents. The calculation of diluted loss per share adjusts the weighted-average shares of common stock outstanding for the dilutive effect of common stock equivalents, including stock options and warrants for the period as determined using the treasury stock method. For purposes of the diluted net loss per share calculation, common stock equivalents are excluded from the calculation because their effect would be anti-dilutive. Therefore, basic and diluted net loss per share applicable to common stockholders is the same for periods with a net loss. The following table illustrates the anti-dilutive potential common stock equivalents excluded from the calculation of loss per share (in thousands): Three Months Ended March 31, 2020 2019 Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share: Stock options 391 610 Convertible debt — 1,352 Warrants 8,604 1,187 8,995 3,149 Fair Value of Financial Instruments GAAP requires disclosing the fair value of financial instruments to the extent practicable for financial instruments that are recognized or unrecognized in the consolidated balance sheet. The fair value of the financial instruments disclosed herein is not necessarily representative of the amount that could be realized or settled, nor does the fair value amount consider the tax consequences of realization or settlement. In assessing the fair value of financial instruments, the Company uses a variety of methods and assumptions, which are based on estimates of market conditions and risks existing at the time. For certain instruments, including accounts receivable and accounts payable, the Company estimated that the carrying amount approximated fair value because of the short maturities of these instruments. All debt is based on current rates at which the Company could borrow funds with similar remaining maturities and approximates fair value. GAAP establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs consist of items that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is described below: Level 1 – Quoted prices in active markets for identical assets or liabilities, there are no fair valued assets or liabilities classified under Level 1 as of March 31, 2020. Level 2 – Observable prices that are based on inputs not quoted on active markets but corroborated by market data, there are no fair valued assets or liabilities classified under Level 2 as of March 31, 2020. Level 3 – Unobservable inputs are used when little or no market data is available; the fair value hierarchy gives the lowest priority to Level 3 inputs (see Note 7). Foreign Currency and Other Comprehensive (Loss)/Income The functional currency of our foreign subsidiary is typically the applicable local currency, which is British Pounds. The translation from the respective foreign currency to United States Dollars (US Dollar) is performed for balance sheet accounts using current exchange rates in effect at the balance sheet date and for income statement accounts using an average exchange rate during the period. Gains or losses resulting from such translation are included as a separate component of accumulated other comprehensive (loss)/income. Gains or losses resulting from foreign currency transactions are included in foreign currency income or loss except for the effect of exchange rates on long-term inter-company transactions considered to be a long-term investment, which is accumulated and credited or charged to other comprehensive income. Transaction gains and losses are recognized in our results of operations based on the difference between the foreign exchange rates on the transaction date and on the reporting date. The foreign currency exchange gains and losses are included as a component of general and administrative expenses in the accompanying Unaudited Condensed Consolidated Statements of Operations. The Company has recognized foreign exchanges gains and losses and changes in accumulated comprehensive income approximately as follows: For the Three Months Ended March 31, 2020 2019 Net foreign exchange transactions: Losses (gains) $ 584,000 $ (89,000 ) Accumulated comprehensive income: Unrealized (gains) losses on currency translation adjustment $ (277,000 ) $ 33,000 The exchange rates adopted for the foreign exchange transactions are the rates of exchange, as quoted on OANDA, a Canadian-based foreign exchange company and internet website providing currency conversion, online retail foreign exchange trading, online foreign currency transfers, and forex information. Translation of amounts from British Pounds into United States dollars was made at the following exchange rates for the respective periods: ● As of March 31, 2020 – British Pounds $1.237295 to US Dollars $1.00. ● The average rate for the three months ended March 31, 2020 – British Pounds $1.280500 to US Dollars $1.00. Subsequent Events Management has evaluated subsequent events or transactions occurring through the date the consolidated financial statements were issued and determined that no events or transactions are required to be disclosed herein, except as disclosed. Recently Issued Accounting Principles In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13 “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” which requires the measurement and recognition of expected credit losses for financial assets held at amortized cost. ASU 2016-13 replaces the existing incurred loss impairment model with an expected loss methodology. In November 2019, the FASB issued ASU No. 2019-10 to postpone the effective date of ASU No. 2016-13 for public business entities eligible to be smaller reporting companies defined by the SEC to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is currently evaluating the impact of this ASC on its consolidated financial statements. Other recent accounting standards issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC did not or are not believed by management to have a material impact on the Company’s present or future condensed consolidated financial statements.

Liquidity and Financial Conditi

Liquidity and Financial Condition	3 Months Ended
	Mar. 31, 2020
Liquidity And Financial Condition
Liquidity and Financial Condition	2 — LIQUIDITY AND FINANCIAL CONDITION The Company incurred a loss from operations of approximately $4.8 million and cash used in operating activities of $4.4 million for the three months ended March 31, 2020. The Company had approximately $5.8 million in working capital, $257 million in accumulated deficits, and $2.5 million of cash on hand as of March 31, 2020. To mitigate any apprehension that the Company may not have the ability to continue as a going concern, we have executed a series of events to remove doubt about the ability to sufficiently fund operations for the next 12 months. The Company also considered the extent of the impact of the COVID-19 pandemic. Capital-raising events During the past six months, the Company has been able to raise funds as follows successfully: ● On November 27, 2019, the Company closed an equity financing for 3,201,200 shares of common stock, pre-funded warrants to purchase 11,893,100 shares of common stock and, 11,320,725 shares of Common Stock underlying the Warrants (collectively, the “Reserve Shares”), for the exclusive benefit of the holders of the Pre-Funded Warrants and the warrants. The Company received gross proceeds of $3,988,096 from the offering, before deducting underwriting-related fees and other offering expenses. The Company is using the net proceeds from equity financing to assist in alleviating the burden of accumulated backorders and provide working capital for daily operating expenditures. ● On February 14, 2020, the Company closed on an equity financing for (i) 12,445,000 shares of common stock, par value $0.00001 per share, of the Company (the “Common Stock”), as well as 12,445,000 warrants (the “Warrants”) to purchase 9,333,750 shares of Common Stock, and (ii) 14,827,200 pre-funded warrants (the “Pre-Funded Warrants”), with each Pre-Funded Warrant exercisable for one share of Common Stock, together with 14,827,200 Warrants to purchase 11,120,400 shares of Common Stock. The Company received gross proceeds of approximately $5,998,000, less offering costs of $560,000 for net proceeds of $5,438,000. ● We filed a shelf registration statement on Form S-3 with the U.S. Securities and Exchange Commission (“SEC”) on May 5, 2020. It was declared effective on May 13, 2020, which may enable us to offer and sell to the public from time to time in one or more offerings, up to $100,000,000 of common and preferred stock, warrants, or units or any combination thereof. There can be no assurance that we will be successful in securing additional capital in sufficient amounts and on terms favorable to us. Strategic Initiatives The Company has taken the following actions to support its liquidity needs as it relates to the auspices of the COVID-19 pandemic: ● Requiring all employees who can work from home to work from home; ● Having employees work in dedicated shifts to lower the risk that all employees who perform similar tasks might become ● Entered into, effective May 1, 2020, a new lease arrangement at two new locations in Hackettstown, NJ, on a 90-day cycle for each site. Effectively lowering rental fees by approximately 81%. ● Implemented proactive spending reductions in the first quarter of fiscal 2020 to improve liquidity, including a partial workforce reduction, the furlough of employees, reduced discretionary spending, resulting in approximately $5.0 million in annual savings. ● Took strategic actions to drive profitability improvements, including the recently completed business optimization. Paycheck Protection Program (“PPP’) and Liquidity As part of the CARES Act, approved by the President on March 27, 2020, the Small Business Administration (“SBA”) can authorize guaranteed loans under the PPP through June 30, 2020, for small businesses who meet the necessary eligibility requirements to keep their workers on the payroll. The Company received approximately $1.2 million on April 10, 2020, under the sponsorship of PPP, in the form of a promissory note. The PPP Loan matures April 5, 2022. It bears interest at a fixed rate of 1.00% per annum, with monthly principal and interest payments as determined by the lender, less the amount of any potential forgiveness (discussed below), commencing on November 5, 2020. The Company did not provide any collateral or guarantees for the PPP Loan. The Promissory Note provides for customary events of default, including, among others, those relating to failure to make a payment, bankruptcy, breaches of representations, and material adverse effects. The Company may prepay the principal of the PPP Loan at any time without incurring any prepayment charges. Loan forgiveness is available for all or a portion of the PPP loan by the SBA or the associated lender. Upon an application by the Company following the protocols set forth under the CARES Act, loan forgiveness is available for the sum of documented payroll costs, covered rent payments, and covered utilities during the eight weeks beginning on the approval date of the PPP Loan. For purposes of the CARES Act, payroll costs exclude compensation of an individual employee more than $100,000, prorated annually. Not more than 25% of the forgiven amount may be for non-payroll expenses. There will be a reduction of the loan forgiveness if: the full-time headcount declines, or if salaries and wages for employees with salaries of $100,000 or less annually are reduced by more than 25%. Although the Company currently believes that its use of the PPP Loan will meet the conditions for the forgiveness of the loan, the Company cannot ensure that its PPP Loan will be forgiven, in whole or in part. The Company intends to use the proceeds for payroll costs, and costs used to continue group health care benefits, mortgage payments, rent, utilities, and interest on other debt obligations. Together, with the above-aforementioned capital raises, the PPP loan, and the Company-wide protocols invoked as a result of the world-wide consequences encountered from the COVID-19 health emergency, we have sufficient funds to continue our operations for at least twelve months from the date of these financial statements. The ability to recognize revenue and ultimately cash receipts is contingent upon, but not limited to, acceptable performance of the delivered equipment and services, and additionally, the uncertain future impact of the COVID-19 pandemic. There may be a material influence in our asset’s carrying value if we are unable to close on some revenue-producing opportunities in the near term, and additionally, the unknown factor of how the Company’s future financial condition may be affected by the COVID-19 pandemic.

Intangible Assets

Intangible Assets	3 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	3 — INTANGIBLE ASSETS Intangible assets consist of the following finite assets: Patents and Licenses Trade Names and Customer Relationships Accumulated Accumulated Accumulated Costs Amortization Costs Amortization Costs Amortization Net Balance as of December 31, 2019 $ 12,378,000 $ (10,504,000 ) $ 1,450,000 $ (690,000 ) $ 2,880,000 $ (2,592,000 ) $ 2,922,000 Additions — — — — — — — Amortization — (167,000 ) — (56,000 ) — (78,000 ) (301,000 ) Balance as of March 31, 2020 $ 12,378,000 $ (10,671,000 ) $ 1,450,000 $ (746,000 ) $ 2,880,000 $ (2,670,000 ) $ 2,621,000 Patents and Licenses: On March 31, 2020, and December 31, 2019, the Company had net capitalized costs of patents and licenses of $1.7 million and $1.9 million, respectively. The Company amortizes patents and licenses that have been filed over their useful lives, which range between 18.5 to 20 years. The costs of provisional patents and pending applications are not amortized until the patent is filed and is reviewed each reporting period to determine if it is likely that the patent will be successfully filed. For the three months ended March 31, 2020, and 2019, the amortization of patents and licenses amounted to $0.2 million each year. Other Intangible Assets: The Company’s remaining intangible assets include the trade names, technology, and customer lists acquired in its acquisition of IMT and Vislink. On March 31, 2020, and December 31, 2019, the Company had net capitalized costs of other intangible assets of $1.0 million, respectively. The Company amortizes these other intangible assets over their estimated useful lives of 3 to 15 years. For the three months ended March 31, 2020, and 2019, the amortization of these other intangible assets amounted to $0.1 million and $0.3 million, respectively. The weighted average remaining life of the amortization of the Company’s intangible assets is approximately 3.6 years. The following table represents the estimated amortization expense for total intangible assets for the succeeding five years: Period ending March 31, 2021 $ 971,000 2022 871,000 2023 365,000 2024 119,000 2025 119,000 Thereafter 176,000 $ 2,621,000

Notes Payable

Notes Payable	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Notes Payable	N O T 4 NOT P YAB L The table below represents the Company’s notes payable as of March 31, 2020, and December 31, 2019: Principal 3/31/20 12/31/19 Effective as of September 27, 2019, the Board of Directors of the Company consented to assume the remaining balance of a note held by a former related party MB Technology Holdings, LLC (“MBTH”). MBTH originally borrowed funds for the benefit of the Company with the proceeds forwarded to the Company reflecting due to a related party, ultimately converted into shares. The note matures on September 18, 2020, with an annual interest rate of 8.022%. One payment of $18,519 of accrued interest plus $230,860 of principal, totaling $249,379, is due on September 18, 2020. For the three months ended March 31, 2020, and 2019, interest expense is approximately $9,900 and $-0-, respectively. $ 231,000 $ 231,000 On October 2, 2019, the Company’s subsidiary, Integrated Microwave Technology (“IMT”), incurred a working capital loan of $150,000, with an annual interest rate of 1.9%, maturing on April 24, 2020. IMT has made $45,366 in principal and $15,424 in interest payments. 62,000 108,000 $ 293,000 $ 339,000

Leases

Leases	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Leases	NOTE 5 — LEASES The Company’s leasing arrangements include agreements for office space, deployment sites, and storage warehouses, both domestically and internationally. The operating leases contain various terms and provisions, with a remaining duration of 3 months to 4.8 years. Certain individual leases contain rent escalation clauses and lease concessions that require additional rental payments in the later years of the term. We recognize rent expense for these types of contracts on a straight-line basis over the minimum lease term. Additionally, the Company sublets a portion of its space under operating leases with various lease terms at Hemel and Billerica locations, with a remaining duration of five to ten months. On January 24, 2020, the Company negotiated a new lease agreement with the landlord at our Billerica location, decreasing square footage required to 8,204 from 39,237 square feet or approximately 79%. The effective date of the new lease agreement is on March 24, 2020, with a reduced monthly obligation expiring on December 31, 2026. Additionally, there was an early termination of a lease agreement and the Company removed approximately $904,000 of Right-Of-Use Assets; $533,000 of Operating Lease Liabilities;$371,000 of Accumulated Amortization on the Operating Lease from the Consolidated Balance Sheet; and recognized a lease termination gain of approximately $21,000 in the Consolidated Statement of Operations and Comprehensive Loss as of March 31, 2020. As of March 31, 2020, ROU. assets and lease liabilities were approximately $2.37 million, net, and $1.72 million ($0.38 million of which is current), respectively. The weighted-average remaining term for lease contracts was 5.0 years on March 31, 2020, with maturity dates ranging from April 2020 to December 2026. The weighted-average discount rate was 9.4% on March 31, 2020. For the three months ended March 31, 2020, and 2019, the Company incurred approximately $258,000 and $297,000 of rental fees, respectively, offset by sublet income of approximately $46,000 and $35,000, under operating leases for the three months ended March 31, 2020, and 2019. Adjustments for straight-line rental expense for the respective periods was not material. As such, the majority of costs recognized is reflected in cash used in operating activities for the respective periods. This expense consisted primarily of payments for base rent on office and warehouse leases. Amounts related to short-term lease costs and taxes and variable service charges on leased properties were immaterial. Besides, we have the right, but no obligation, to renew individual leases for various renewal terms. The following table illustrates specific operating lease data for the three months ending March 31, 2020, and 2019: For the Three Months Ended March 31, 2020 2019 Lease cost: Operating lease cost $ 202,000 $ 301,000 Short-term lease cost 102,000 31,000 Variable lease cost — — Sublease income (46,000 ) (35,000 ) Total lease cost $ 258,000 $ 297,000 Cash paid for amounts in lease liabilities: Operating cash flows from operating leases $ 253,000 $ 310,000 Right-of-use assets obtained in exchange for new operating lease liabilities $ 546,000 $ 2,899,000 Weighted-average remaining lease term—operating leases 5.0 years 3.61 years Weighted-average discount rate—operating leases 9.4 % 9.2 % Maturities of our operating lease liabilities were as follows as of March 31, 2020: Amount 2021 $ 534,000 2022 395,000 2023 370,000 2024 356,000 2025 188,000 Total undiscounted operating lease payments 2,202,000 Less: amount representing an imputed interest 487,000 The present value of operating lease liabilities $ 1,715,000 Sublets: 2020 $ 51,000 2021 — $ 51,000 The table below lists the location and lease expiration date from 2020 through 2026: Location Lease-End Date Approximate Future Payments Colchester, UK – Waterside House Mar 2025 $ 1,280,000 Hemel, UK. Oct 2020 101,000 Singapore Jul 2020 12,000 Anaheim, CA Jul 2021 41,000 Hackettstown, NJ Apr 2020 7,000 Sarasota, FL Sep 2022 86,000 Billerica, MA Dec 2026 675,000 Sublets: Hemel, UK. Oct 2020 $ 51,000

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2020
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 6 — RELATED PARTY TRANSACTIONS The Company executed an amended related party agreement with MB Merchant Group, LLC (“MBMG”), on February 25, 2020, agreeing to provide only the following services to the Company: ● to conduct merger and acquisition searches, negotiating and structuring deal terms and other related services in connection with suitable closing acquisitions for the Company, ● to seek and secure financing for the Company, except in those regions in which the Company had previously appointed a business representative to explore such opportunities exclusively, subject in each case to prior approval by the Company’s Chief Executive Officer on a case-by-case basis. MBMG will no longer provide strategic planning and financial structuring services or technical consulting services, review patent applications, or provide consulting services concerning specific legal matters. Lastly, the Company negotiated the final settlement of a remaining balance due to MBMG of nearly $561,000 remitting approximately $230,000, recognizing a gain on settlement of related party obligations in the amount of $331,000. MBMG is an affiliate of Richard L. Mooers, a director of the Company, and Roger G. Branton, a director and former Chief Financial Officer of the Company. The following table represents a summary of related party transactions for the three months ended March 31, 2020, and 2019: For the three months ended March 31, 2020 2019 Consulting fees incurred, recurring $ 200,000 $ 150,000 Consulting fees incurred, non-recurring $ 120,000 $ 25,000 Common stock issued in satisfaction of amounts due: Quantity of shares issued — 8,159 Value of shares issued $ — $ 30,000 Amounts repaid to MBMG in cash $ *825,000 $ 230,000 *includes a final settlement in the amount of $230,000 The Company recorded fees incurred in general and administrative expenses on the accompanying Consolidated Statements of Operations and included such payments due to related parties on the Consolidated Balance Sheet. The balances outstanding to MBMG on March 31, 2020, and December 31, 2019, were $-0- and $505,000, respectively.

Derivative Liabilities

Derivative Liabilities	3 Months Ended
	Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liabilities	NOTE 7 — DERIVATIVE LIABILITIES Each of the warrants issued in connection with the August 2015 underwritten offering, the February 2016 Series B Preferred Stock Offering, the May 2016 financing, the July 2016 financing, the August 2017 underwritten offering, and the May 2018 Financing have been accounted for as derivative liabilities as each of the warrants contain a net cash settlement provision whereby, upon certain fundamental events, the holders could put the warrants back to the Company for cash. The following are the critical assumptions used in connection with the valuation of the warrants exercisable into common stock as of March 31, 2020, and 2019: Three Months Ended March 31, 2020 2019 Number of shares underlying the warrants 462,428 492,815 Fair market value of stock $ 0.16 $ 3.50 Exercise price $ 0.0265 to $ 137.90 $ 4.50 to $ 137.90 Volatility 123% to 175 % 81% to 148 % Risk-free interest rate 0.17% to 0.29 % 2.21% to 2.27 % Expected dividend yield — — Warrant life (years) 1.1 to 3.2 0.8 to 4.2 Level 3 liabilities are valued using unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the liabilities. For fair value measurements categorized within Level 3 of the fair value hierarchy, the Company’s accounting and finance department, which reports to the Chief Financial Officer, determines its valuation policies and procedures. The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s accounting and finance department and are approved by the Chief Financial Officer. Level 3 Valuation Techniques: Level 3 financial liabilities consist of the derivative liabilities for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. The Company deems financial instruments that do not have fixed settlement provisions to be derivative instruments. Under US GAAP, the fair value of these warrants is classified as a liability on the Company’s consolidated balance sheets because, according to the terms of the warrants, a fundamental transaction could give rise to an obligation of the Company to pay cash to its warrant holders. Such instruments do not have fixed settlement provisions and have also been recorded as derivative liabilities. Corresponding changes in the fair value of the derivative liabilities are recognized in earnings on the Company’s consolidated statements of operations in each subsequent period. The Company’s derivative liabilities are carried at fair value and were classified as Level 3 in the fair value hierarchy due to the use of significant unobservable inputs. To calculate fair value, the Company uses a binomial model style simulation, as the standard Black-Scholes model would not capture the value of certain features of the warrant derivative liabilities. The following table sets forth a summary of the changes in the fair value of our Level 3 financial liabilities that are measured at fair value on a recurring basis: Three Months Ended March 31, 2020 2019 Beginning balance $ 30,000 $ 1,118,000 Recognition of warrant liabilities on issuance dates — — Re-classification to equity upon warrants exercised — Change in fair value of derivative liabilities (17,000 ) 74,000 Ending balance $ 13,000 $ 1,192,000

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Stockholders' Equity	NOTE 8 — STOCKHOLDERS’ EQUITY Common Stock Issuances During the three months ended March 31, 2020, the Company: ● On February 14, 2020, the Company closed on an equity financing for 12,445,000 shares of common stock, 12,445,000 warrants to purchase 9,333,750 shares of Common Stock, 14,827,200 pre-funded warrants, with each Pre-Funded Warrant exercisable for one share of Common Stock, and together with 14,827,200 Warrants to purchase 11,120,400 shares of Common Stock. The holders of these warrants are limited to settlement in shares of common stock; there is no provision for net cash settlement alternatives; therefore, the Company classified these warrants as equity. The Company received gross proceeds of approximately $5,998,000, less offering costs of $712,000 for net proceeds of $5,286,000. The Company has earmarked the use of the net proceeds from equity financing for working capital and general corporate purposes. ● issued 47,088,398 shares of common stock for the exercise of 56,127,764 pre-funded and public warrants, upon exercise of the holders, receiving approximately $9,600 in net proceeds. Common stock warrants During the three months ended March 31, 2020, the Company granted 42,099,400 warrants, 56,127,764 warrants were exercised by their holders, and 5,374 warrants expired. The weighted average exercise prices of warrants outstanding at March 31, 2020, is $2.00 with a weighted average remaining contractual life of 1.0 years. As of March 31, 2020, these outstanding warrants contained no intrinsic value. The following table sets forth common stock purchase warrants outstanding as of March 31, 2020: Quantity of Warrants (in Weighted Average Exercise Price Outstanding, December 31, 2019 25,125,447 $ 1.10 Warrants granted 42,099,400 $ 0.20 Warrants exercised (56,127,764 ) $ (0.20 ) Warrants cancelled/expired (5,374 ) $ (411.80 00 ) Outstanding, March 31, 2020 11,094,709 $ 2.00 Exercisable, March 31, 2020 11,094,709 $ 2.00 Common Stock Options During the three months ended March 31, 2020, and 2019, the Company recorded approximately $386,000 and $609,000, respectively, as stock compensation expense from the amortization of stock options issued. As of March 31, 2020, the weighted average remaining contractual life was 7.25 years for options outstanding and 7.13 years for options exercisable. There was no intrinsic value of the stock options on March 31, 2020. As of March 31, 2020, the remaining expense is approximately $0.26 million over the remaining amortization period of 1.2 years. The Company estimates forfeiture and volatility using historical information. The risk-free interest rate is based on the implied yield available on US Treasury zero-coupon issues over the equivalent lives of the options. The expected life of the options represents the estimated period using the simplified method. The Company has not paid dividends on its common stock, and no assumption of dividend payment(s) is made in the model. The weighted average fair value of options granted during the three months ended March 31, 2020, and 2019, which was $-0- and $0.89, respectively. Each option is estimated on the date of grant, using the Black-Scholes model and the following assumptions (all in weighted averages): For the three months ended March 31, 2020 2019 Exercise price $ -0- $ 0.89 Volatility 0 % 149.22 % Risk-free interest rate 0 % 2.68 % Expected dividend yield 0 % 0 % Expected term (years) 0 6 The risk-free rate is based on the rate for the US Treasury note over the expected term of the option. The expected term for employees represents the period that options granted are expected to be outstanding using the simplified method, a s the Company’s historical share option exercise experience does not provide a reasonable basis upon which to estimate the expected term. For non-employee options, the expected term is the full term of the option. Expected volatility is based on the average of the weekly share price changes over the shorter of the expected term or the period from the placement on Nasdaq Capital Markets Exchange to the date of the grant. A summary of the status of the Company’s stock option plan for the period ended March 31, 2020, is as follows: Number of Options (in shares) Weighted Average Exercise Price Outstanding, December 31, 2019 505,050 $ 14.83 Options granted — $ — Options exercised — $ — Options canceled/expired (19,000 ) $ (14.98 ) Outstanding, March 31, 2020 486,050 $ 14.83 Exercisable, March 31, 2020 391,424 $ 15.42 CEO. Inducement Award — Time Vested Option On January 22, 2020, as part of the CEO’s employment agreement, an inducement award of a ten year, non-statutory, option to purchase 2,155,481 shares of the Company stock was granted. The award has an exercise price of $0.285, vesting commencement date of January 22, 2020, expiration date of January 22, 2030, and the options vest as follows: 25% of the Option Shares shall vest on the first anniversary of the Vesting Commencement Date; and, the remaining 75% will vest in substantially equal monthly installments over the thirty-six (36) month period following the first anniversary of the Vesting Commencement Date. For the time vested option award, the compensation cost is measured based on the fair value of an award at the date of the grant. The Company uses the Black Scholes-Merton formula as a valuation technique under the guidance of ASC. Topic 718 for estimating the fair values of employee share options and similar instruments. For employee equity-classified awards, compensation cost is recognized over the employee’s requisite service period with a corresponding credit to equity (additional paid-in capital). The employee’s requisite service period begins at the service inception date and ends when the requisite service has been provided. In determining the award’s grant-date fair value, the following assumptions were used (all in weighted averages): For the three months ended March 31, 2020 2019 Exercise price $ .285 $ — Volatility 153.02 % — Risk-free interest rate 1.57 % — Expected dividend yield 0 % — Expected term (years) 6.3 — The risk-free rate is based on the rate for the US Treasury note over the expected term of the option. The expected term for employees represents the period that options granted are expected to be outstanding using the simplified method, as the Company’s historical share option exercise experience does not provide a reasonable basis upon which to estimate the expected term. For non-employee options, the expected term is the full term of the option. Expected volatility is based on the average of the weekly share price changes over the shorter of the expected term or the period from the placement on Nasdaq Capital Markets Exchange to the date of the grant. The Company estimates forfeiture and volatility using historical information. The risk-free interest rate is based on the implied yield available on US Treasury zero-coupon issues over the equivalent lives of the options. The expected life of the options represents the estimated period using the simplified method. The Company has not paid dividends on its common stock, and no assumption of dividend payment(s) is made in the model. The weighted average fair value of options granted during the three months ended March 31, 2020, and 2019 was $0.275 and $-0-, respectively. As of March 31, 2020, the weighted average remaining contractual life was 9.82 years for options outstanding and options exercisable, respectively. The intrinsic value of options exercisable at March 31, 2020, was $-0-. During the three months ended March 31, 2020, and 2019, the Company recorded approximately $18,000 and $-0-, respectively, as stock compensation expense from the amortization of time vested stock options issued. As of March 31, 2020, the remaining stock compensation expense is approximately $574,000, with 3.81 years remaining for the amortization period. A summary of the status of the Company’s time vested stock option plan for the period ended March 31, 2020, is as follows: Number of Options (in shares) Weighted Average Exercise Price Outstanding, December 31, 2019 — $ — Options granted 2,155,481 $ .2745 Options exercised — $ — Options canceled/expired — $ Outstanding, March 31, 2020 2,155,481 $ .2662 Exercisable, March 31, 2020 — $ — CEO. Inducement Award — Performance-Based Option On January 22, 2020, as part of the CEO’s employment agreement, an inducement award of a ten year, non-statutory, option to purchase 1,500,000 shares of the Company stock was granted. The award has an exercise price of $0.285, vesting commencement date of January 22, 2020, expiration date of January 22, 2030. The Option Shares will vest in three (3) equal tranches upon attainment of the following applicable performance conditions for each tranche; provided that the Executive remains in continuous employment with the Company through the date on which: ● Tranche 1: 500,000 Option Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $6,000,000 accumulated over four consecutive fiscal quarters. ● Tranche 2: 500,000 Option Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $15,000,000 accumulated over four consecutive fiscal quarters. ● Tranche 3: 500,000 Option Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $23,000,000 accumulated over four consecutive fiscal quarters. For the performance-based option award, the compensation cost is measured based on the fair value of an award at the date of the grant. The Company uses the Black Scholes-Merton formula as a valuation technique under the guidance of ASC. Topic 718 for estimating the fair values of employee share options and similar instruments. For employee equity-classified awards, compensation cost is recognized over the employee’s requisite service period with a corresponding credit to equity (additional paid-in capital). The employee’s requisite service period begins at the service inception date and ends when the requisite service has been provided. In determining the award’s grant-date fair value, the following assumptions were used (all in weighted averages): For the three months ended March 31, 2020 2019 Exercise price $ .285 $ — Volatility 153.02 % — Risk-free interest rate 1.57 % — Expected dividend yield 0 % — Expected term (years) 6.5 — The risk-free rate is based on the rate for the US Treasury note over the expected term of the option. The expected term for employees represents the period that options granted are expected to be outstanding using the simplified method, as the Company’s historical share option exercise experience does not provide a reasonable basis upon which to estimate the expected term. For non-employee options, the expected term is the full term of the option. Expected volatility is based on the average of the weekly share price changes over the shorter of the expected term or the period from the placement on Nasdaq Capital Markets Exchange to the date of the grant. The Company estimates forfeiture and volatility using historical information. The risk-free interest rate is based on the implied yield available on US Treasury zero-coupon issues over the equivalent lives of the options. The expected life of the options represents the estimated period using the simplified method. The Company has not paid dividends on its common stock, and no assumption of dividend payment(s) is made in the model The weighted average fair value of options granted during the three months ended March 31, 2020, and 2019 was $0.276 and $-0-, respectively. As of March 31, 2020, the weighted average remaining contractual life was 9.82 years for options outstanding and options exercisable, respectively. The intrinsic value of options exercisable at March 31, 2020, was $-0-. As of March 31, 2020, the Company is unable to determine the probability that any of the required metrics for vesting will be achieved. The unrecognized stock-based compensation expense for the performance-based award was approximately $414,000 as of March 31, 2020. When the Company determines that the remaining performance metrics’ achievement becomes probable, the Company will record a cumulative catch-up stock-based compensation amount, and the remaining unrecognized amount will be recorded over the remaining requisite service period of the awards. A summary of the status of the Company’s performance-based stock option plan for the period ended March 31, 2020, is as follows: Number of Options (in shares) Weighted Average Exercise Price Outstanding, December 31, 2019 — $ — Options granted 1,500,000 $ .2758 Options exercised — $ — Options canceled/expired — $ Outstanding, March 31, 2020 1,500,000 $ .2758 Exercisable, March 31, 2020 — $ —

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 9 — COMMITMENTS AND CONTINGENCIES Legal: The Company is subject, from time to time, to claims by third parties under various legal theories. The defense of such claims, or any adverse outcome relating to any such claims, could have a material adverse effect on the Company’s liquidity, financial condition, and cash flows. According to ASC Topic 450’s provision that a company must accrue a loss contingency if the information is available before the issuance of the financial statements, it has been determined that based upon a lawsuit filed by Hale Capital Partners, LP (“Hale”) against the Company on July 29, 2019, the Company may be potentially liable for professional fees incurred by Hale for a due diligence transaction in the amount of $140,000. The Company deems these fees excessive and is vigorously defending the claim, including asserting counterclaims against Hale. This amount was accrued and included in accrued expenses in the condensed consolidated balance sheet as of March 31, 2020. There were no other material legal actions pending. Pension: The Company, at its discretion, may make matching contributions to the 401(k) plan in which its employees participate. For the three months ended March 31, 2020, and 2019, the Company did not make matching contributions. The Company currently operates a Group Personal Pension Plan in its UK subsidiary, and funds are invested with Royal London. UK employees are entitled to join the plan to which the Company contributes varying amounts subject to status. Also, the Company operates a stakeholder pension scheme in the UK for the three months ended March 31, 2020, and 2019, and the Company made matching contributions of $43,000 and 33,000, respectively. Nasdaq Compliance: On September 26, 2019, we received a written notification from the Nasdaq Stock Market L.L.C. (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) as the Company’s closing bid price was below $1.00 per share for the previous thirty (30) consecutive business days. The Company was subject to an initial 180-calendar day compliance period granted through the Nasdaq Listing Rule 5810(c)(3)(A), or until March 24, 2020, to regain compliance with the minimum bid price requirements. On March 25, 2020, the Company received notice from Nasdaq indicating that, while the Company has not regained compliance with the Minimum Bid Price Requirement, Nasdaq has determined that the Company is eligible for an additional 180-day period, or until September 21, 2020, to regain compliance. The Nasdaq staff’s determination was based on (i) the Company meeting the continued listing requirement for the market value of its publicly held shares and all other Nasdaq initial listing standards, except for the Minimum Bid Price Requirement, and (ii) the Company providing written notice to Nasdaq of its intent to cure the deficiency during this second compliance period, if necessary by effecting a reverse stock split. If at any time during this second 180-day period, the closing bid price of the Common Stock is at least $1 per share for a minimum of 10 consecutive business days, Nasdaq has stated that they will provide the Company with written confirmation of compliance. If compliance cannot be demonstrated by September 21, 2020, Nasdaq will provide written notification that the Common Stock will be delisted. At that time, the Company may appeal Nasdaq’s determination to its hearings panel. On April 17, 2020, the Company received written notice from Nasdaq that Nasdaq has determined to toll the compliance periods for bid price and market value of publicly held shares (“MVPHS”) requirements (collectively, the “Price-based Requirements”) through June 30, 2020. As a result, companies presently in compliance periods or any Price-based Requirements will remain at that same stage of the process and will not be subject to being delisted for these concerns. Starting on July 1, 2020, companies will receive the balance of any pending compliance period in effect at the start of the tolling period to regain compliance. Accordingly, since the Company had 158 calendar days remaining in its bid price compliance period as of April 16, 2020, it will, upon reinstatement of the Price-based Requirements, still have 158 calendar days from July 1, 2020, or until December 7, 2020, to regain compliance. The Company can regain compliance, either during the suspension or during the compliance period resuming after the suspension, by evidencing compliance with the Price-based Requirements for a minimum of 10 consecutive trading days. If the Company does not regain compliance within the allotted compliance period(s), including any extensions that may be granted by Nasdaq, Nasdaq will provide notice that the Company’s shares of common stock will be subject to delisting. The Company intends to monitor its closing bid price for its common stock between now and December 7, 2020, and will consider available options to resolve the Company’s noncompliance with the minimum bid price requirement, as may be necessary. There can be no assurance that the Company will be able to regain compliance with the minimum bid price requirement or will otherwise comply with other Nasdaq listing criteria. On April 30, 2020, Vislink Technologies, Inc. (the “Company”) received a public reprimand letter (the “Letter”) from the staff (the “Staff”) of the Listing Qualifications Department of The Nasdaq Stock Market L.L.C. (“Nasdaq”). The Letter notified the Company that it’s recent offering of 12,445,000 shares of common stock, par value $0.00001 per share, of the Company (“Common Stock”), pre-funded warrants to purchase 14,827,200 shares of Common Stock, and warrants to purchase up to 20,454,150 shares of Common Stock, completed on February 14, 2020 (the “Offering”) did not satisfy Nasdaq Listing Rule 5635(d) because (a) the Staff determined that the Offering did not meet the Nasdaq definition of a public offering under Listing Rule IM-5635-3 and (b) the Offering involved the issuance of 20% or more of the pre-transaction shares outstanding at less than the minimum price, as defined by Nasdaq rules. Consequently, the Staff determined that approval by the shareholders of the Company was required for the Offering, and because such shareholder approval was not received, the Staff concluded that the Company violated the Nasdaq’s shareholder approval rules. Additionally, the Letter notified the Company that on two separate occasions following transactions completed in November 2019 and February 2020, the Company failed to file a Change in Outstanding Shares form, as required by Listing Rule 5250(e)(1), which filings were subsequently made on March 12, 2020. The Staff determined that delisting the Company’s Common Stock was not an appropriate sanction and closed its review by issuing the public reprimand letter under Nasdaq Listing Rule 5810(c)(4). As previously reported on a Current Report on Form 8-K, filed with the US Securities and Exchange Commission on February 14, 2020, based on Nasdaq’s published rules and published guidance at the time of the Offering, the Company believed the Offering was a “public offering” under Rule 5635(d). The receipt of the Letter does not affect the listing of the Company’s Common Stock. If the Company’s common stock is delisted from the Nasdaq Capital Market and is not eligible for quotation on another market or exchange, trading of its common stock could be conducted in the over-the-counter market or on an electronic bulletin board established for unlisted securities such as those sponsored by the OTC. Markets Group. In such event, it could become more difficult to dispose of or obtain accurate price quotations for, the Company’s common stock, and there would likely also be a reduction in the Company’s coverage by securities analysts and the news media, which could cause the price of its common stock to decline further. Also, if not listed on a major exchange, the Company may have difficulty in raising additional capital.

Concentrations

Concentrations	3 Months Ended
	Mar. 31, 2020
Risks and Uncertainties [Abstract]
Concentrations	NOTE 10 — CONCENTRATIONS Customer concentration risk During the three months ended March 31, 2020, approximately 16% of the Company’s revenue was generated from a single customer exceeding 10% of the Company’s total consolidated sales for approximately $854,000. During the three months ended March 31, 2019, the Company did not record sales to any single customer exceeding 10% of the Company’s total consolidated sales. On March 31, 2020, approximately 15% of the Company’s consolidated net accounts receivable was due from one customer for approximately $605,000. On March 31, 2019, approximately 12% of the Company’s consolidated net accounts receivable were due from one customer for approximately $649,000. Vendor concentration risk During the three months ended March 31, 2020, approximately 36% of the Company’s consolidated inventory purchases were generated from one vendor for approximately $1,084,000. During the three months ended March 31, 2019, approximately 43% of the Company’s consolidated inventory purchases were generated from one vendor for approximately $2,467,000. On March 31, 2020, approximately 15% from one vendor and two vendors at 11% each of the Company’s consolidated accounts payable was generated from a total of three vendors for approximately $634,000, $494,000 and $459,000, respectively. As of March 31, 2019, the Company did not record accounts payable to a single vendor exceeding 10% of the Company’s consolidated accounts payable.

Revenue

Revenue	3 Months Ended
	Mar. 31, 2020
Revenue from Contract with Customer [Abstract]
Revenue	NOTE 11 – REVENUE The Company has one operating segment, and the decision-making group is the senior executive management team. In the following table, revenue is disaggregated by primary geographical markets and revenue sources. Three Months Ended Three Months Ended March 31, 2020 March 31, 2019 Primary geographical markets: North America $ 2,076,000 $ 3,919,000 South America 21,000 19,000 Europe 1,963,000 2,350,000 Asia 105,000 1,390,000 Rest of World 1,187,000 528,000 $ 5,352,000 $ 8,206,000 Primary revenue source: Equipment sales $ 4,980,000 $ 7,561,000 Installation, integration and repairs 329,000 601,000 Warranties 43,000 44,000 $ 5,352,000 $ 8,206,000 Long-Lived Assets: United States $ 4,298,000 $ 6,119,000 United Kingdom 1,993,000 2,758,000 $ 6,291,000 $ 8,877,000

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	NOTE 12 — SUBSEQUENT EVENTS Pa y c c i o As part of the CARES Act, approved by the President on March 27, 2020, the Small Business Administration (“SBA”) can authorize guarantee loans under the PPP through June 30, 2020, for small businesses who meet the necessary eligibility requirements to keep their workers on the payroll. The Company received approximately $1.2 million on April 10, 2020, under the sponsorship of PPP, in the form of a promissory note. The PPP Loan matures April 5, 2022. It bears interest at a fixed rate of 1.00% per annum, with monthly principal and interest payments as determined by the lender, less the amount of any potential forgiveness, commencing on November 5, 2020. The Company did not provide any collateral or guarantees for the PPP Loan. The Promissory Note provides for customary events of default, including, among others, those relating to failure to make a payment, bankruptcy, breaches of representations, and material adverse effects. The Company may prepay the principal of the PPP Loan at any time without incurring any prepayment charges. Other events after March 31, 2020, to the date of this report Quantity of Warrants Exercised Quantity of Common Warrant Exercises: Cashless Warrants: Nov 2019 Equity Raise 20,000 15,000 Feb 2020 Equity Raise 9,547,836 7,160,877 9,567,836 7,175,877

Organization and Summary of S_2

Organization and Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Description of Business	Description of Business The overarching strategy of Vislink Technologies, Inc. (“Vislink Technologies,” the “Company,” “we,” “our” or “us”) is to design, develop and deliver advanced wireless communications solutions that provide customers within target markets with enhanced levels of reliability, mobility, performance and efficiency in their business operations and missions. Vislink Technologies’ business lines include the leading brands Integrated Microwave Technologies LLC (“IMT”) and Vislink Communications Systems (“Vislink” or “VCS”). There is considerable brand interaction, due to complementary market focus, compatible product, and technology development roadmaps, and solution integration opportunities. IMT: The IMT business develops, manufactures, and sells microwave communications equipment utilizing COFDM (Coded Orthogonal Frequency Division Multiplexing) technology. COFDM is a transmission technique that combines encoding technology with OFDM (Orthogonal Frequency Division Multiplexing) modulation to provide the low latency and high image clarity required for real-time live broadcasting video transmissions. IMT has extensive experience in ultra-compact COFDM wireless technology, which has allowed IMT to develop integrated solutions over the past 20 years that deliver reliable video footage captured from both aerial and ground-based sources to fixed and mobile receivers’ locations. IMT provides product and service solutions marketed under the well-established brand names Nucomm, RF Central, and IMT. Its video transmission products primarily address three major market areas: broadcasting, sports and entertainment, and surveillance (for military and government). Vislink: Vislink specializes in the wireless capture, delivery, and management of secure, high-quality, live video from the field to the point of usage. Vislink designs and manufactures products encompassing microwave radio components, satellite communication, cellular and wireless camera systems, and associated amplifier items. Vislink serves two core markets: (i) broadcast and media and (ii) law enforcement, and surveillance. In the broadcast and media market, Vislink provides broadcast communication links for the collection of live news and sports and entertainment events. Customers in this market include national broadcasters, multi-channel broadcasters, network owners and station groups, sports and live broadcasters, and hosted service providers. In the law enforcement and surveillance market, Vislink provides secure video communications and mission-critical solutions for law enforcement, defense, and homeland security applications. Its law enforcement and surveillance customers include metropolitan, regional, and national law enforcement agencies, as well as domestic and international defense agencies and organizations.
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements are prepared under the United States generally accepted accounting principles (“US GAAP”) for interim financial information and following the instructions to Form 10-Q and Regulation S-X. Accordingly, these financial statements do not include all information or notes required by GAAP for annual financial statements. They should be read in conjunction with the consolidated financial statements as filed on the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, filed with the United States Securities and Exchange Commission (the “SEC”) on April 1, 2020. In the opinion of management, the unaudited condensed consolidated financial statements included herein contain all adjustments necessary to present fairly the Company’s consolidated financial position as of March 31, 2020, the results of its operations and cash flows for the three months ended March 31, 2020, and 2019. Such adjustments are of a normal recurring nature. The results of operations for the three months ended March 31, 2020, may not be indicative of results for a full year, any other interim period or any future year period.
Principles of Consolidation	Principles of Consolidation The accompanying financial statements have been prepared in conformity with US GAAP as found in the Accounting Standards Codification (“ASC”), the Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”) and the rules and regulations of the SEC. The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, IMT and Vislink. All intercompany accounts and transactions among consolidated entities were eliminated upon consolidation.
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company’s consolidated financial statements include the useful lives of property, plant, and equipment, impairment of long-lived assets, allowance for accounts receivable doubtful accounts, allowance for inventory obsolescence reserve, allowance for deferred tax assets, valuation of warranty reserves, contingent consideration liabilities, and the accrual of potential liabilities. Actual results could differ from these estimates. There have been no new or material changes to the accounting estimates discussed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019, that are of significance, or potential significance, to the Company.
Risks and Uncertainties	Risks and Uncertainties We are subject to risks and uncertainties as a result of the COVID-19 pandemic. The extent of the impact of this pandemic on the Company’s business is highly uncertain and difficult to predict, as the response to this plight may still be in its emerging stages, and information is rapidly evolving. The capital markets and economies worldwide experienced inopportune circumstances from the COVID-19 pandemic, and such adverse events may cause a local or global economic recession. Any economic disruption could have a disadvantageous material effect on our business and reduce our capital resources and access to capital, with possible unfavorable implications on our financial condition and results of operations. Policymakers around the globe have responded with fiscal policy actions to support their industries and economies, but the magnitude and overall effectiveness of these interventions remain uncertain. The severity of the COVID-19 pandemic’s impact on the Company’s business depends on several factors, including the pandemic’s duration and effect on the Company’s customers, which cannot be predicted at this time. There may also be an adverse impact on the Company’s future results of operation and liquidity, and the Company may experience delays in payments of outstanding accounts receivable, supply chain disruptions, and weakening demand. It is uncertain to what extent the COVID-19 pandemic may materially impact the Company’s financial condition, amongst any initiatives or programs that the Company may undertake, if any, as of the date of the issuance of these unaudited condensed consolidated financial statements. The Company can give no assurance that a material impact on the Company’s financial condition has not resulted or will not result in the future.
Inventories	Inventories The Company records inventory at the lower of cost, on a first-in, first-out basis, or net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Inventory valuation adjustments are on the face of the unaudited condensed consolidated statements of operations for the three months ended March 31, 2020, and 2019.
Revenue Recognition	Revenue Recognition We account for the Company’s operating results under ASC Topic 606 adopted on January 1, 2019. It is a comprehensive revenue recognition model that requires revenue to be recognized when the Company transfers control of the promised goods or services to our customers at an amount that reflects the consideration that we expect to receive. The application of ASC Topic 606 requires us to use more judgment and make more estimates than under previously issued guidance. The Company generates all its revenue from contracts with customers. The Company recognizes revenue when we satisfy a performance obligation by transferring control of the promised goods or services to a customer in an amount that reflects the consideration that we expect to receive in exchange for those services. The Company determines revenue recognition through the following steps: 1. Identification of the contract, or contracts, with a customer; 2. Identification of the performance obligations in the contract; 3. Determination of the transaction price; 4. Allocation of the transaction price to the performance obligations in the contract; and 5. Recognition of revenue, when, or as, we satisfy a performance obligation. At contract inception, the Company assesses the goods and services promised in our contracts with customers and identifies a performance obligation for each. To determine the performance obligations, the Company considers all the products and services promised in the contract regardless of whether they are explicitly stated or implied by customary business practices. The timing of satisfaction of the performance obligation is not subject to significant judgment. We measure revenue as the amount of consideration we expect to receive in exchange for transferring goods and services. Excluded from income are the value-added sales taxes, and other charges we collect concurrent with revenue-producing activities. Remaining performance obligations, or backlog, represents the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less.
Leases	Leases We determine if an arrangement is a lease at inception. We recognize lease expense for lease payments on a straight-line basis over the lease term. The Company includes operating leases as ROU assets as “Right of use assets, operating leases” in the consolidated balance sheets. For lease liabilities, operating lease liabilities are included in “Operating lease obligations, current” and “Operating lease liabilities, net of current portion,” in the consolidated balance sheets. We recognize Operating lease ROU assets and liabilities on the commencement date based on the present value of lease payments for all leases with a term longer than 12 months. There is no separation of lease and non-lease components for all our contracts of real estate. The ROU. asset and related lease liabilities recorded under ASC 842 are calculated based on the present value of the lease payments using (1) the rate implicit in the lease or (2) the lessee’s incremental borrowing rate (“IBR”), defined as the rate of interest that a lessee would have to pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a comparable economic environment. As most of our leases do not provide an implicit rate, we generally use our incremental borrowing rates based on an analysis of prior collateralized borrowings over similar terms of the lease payments at the commencement date, to estimate the IBR under ASC 842. There were no capital leases, which are now titled “finance leases” under ASC 842, in the Company’s lease portfolio as of March 31, 2020.
Stock-Based Compensation	Stock-Based Compensation The Company accounts for stock compensation with persons classified as employees for accounting purposes following ASC 718 “Compensation – Stock Compensation,” which recognizes awards at fair value on the date of grant and recognition of compensation over the service period for awards expected to vest. The fair value of stock options is determined using the Black-Scholes Option Pricing Model. The fair value of common stock issued for services is determined based on the Company’s stock price on the date of issuance. Under ASU 2018-07, the scope of Topic 718 was expanded to include share-based payment transactions for acquiring goods and services from non-employees. Equity-classified non-employee share-based payment awards are no longer measured at the earlier of the date at which a commitment for performance by the counterparty is reached or the date at which the counterparty’s performance is complete. Instead, they are now measured at the grant date. Non-employee share-based payment awards with performance conditions are measured at the lowest aggregate fair value under today’s guidance, which often results in zero value. ASU 718 aligns the accounting for non-employee share-based payment awards with performance conditions with accounting for employee share-based payment awards under Topic 718 by requiring entities to consider the probability of satisfying performance conditions. Current guidance requires entities to use the contractual term for the measurement of the non-employee share-based payment awards. ASU 718 allows entities to make an award-by-award election to use either the expected term (consistent with employee share-based payment awards) or the contractual term for non-employee awards
Loss Per Share	Loss Per Share The Company reports a loss per share under ASC Topic 260, “Earnings Per Share,” which establishes standards for computing and presenting earnings per share. The calculation of basic loss per share of common stock divides the net loss allocable to common stockholders by the weighted-average shares of common stock outstanding during the period, without consideration of common stock equivalents. The calculation of diluted loss per share adjusts the weighted-average shares of common stock outstanding for the dilutive effect of common stock equivalents, including stock options and warrants for the period as determined using the treasury stock method. For purposes of the diluted net loss per share calculation, common stock equivalents are excluded from the calculation because their effect would be anti-dilutive. Therefore, basic and diluted net loss per share applicable to common stockholders is the same for periods with a net loss. The following table illustrates the anti-dilutive potential common stock equivalents excluded from the calculation of loss per share (in thousands): Three Months Ended March 31, 2020 2019 Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share: Stock options 391 610 Convertible debt — 1,352 Warrants 8,604 1,187 8,995 3,149
Fair Value of Financial Instruments	Fair Value of Financial Instruments GAAP requires disclosing the fair value of financial instruments to the extent practicable for financial instruments that are recognized or unrecognized in the consolidated balance sheet. The fair value of the financial instruments disclosed herein is not necessarily representative of the amount that could be realized or settled, nor does the fair value amount consider the tax consequences of realization or settlement. In assessing the fair value of financial instruments, the Company uses a variety of methods and assumptions, which are based on estimates of market conditions and risks existing at the time. For certain instruments, including accounts receivable and accounts payable, the Company estimated that the carrying amount approximated fair value because of the short maturities of these instruments. All debt is based on current rates at which the Company could borrow funds with similar remaining maturities and approximates fair value. GAAP establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs consist of items that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is described below: Level 1 – Quoted prices in active markets for identical assets or liabilities, there are no fair valued assets or liabilities classified under Level 1 as of March 31, 2020. Level 2 – Observable prices that are based on inputs not quoted on active markets but corroborated by market data, there are no fair valued assets or liabilities classified under Level 2 as of March 31, 2020. Level 3 – Unobservable inputs are used when little or no market data is available; the fair value hierarchy gives the lowest priority to Level 3 inputs (see Note 7).
Foreign Currency and Other Comprehensive (Loss)/Income	Foreign Currency and Other Comprehensive (Loss)/Income The functional currency of our foreign subsidiary is typically the applicable local currency, which is British Pounds. The translation from the respective foreign currency to United States Dollars (US Dollar) is performed for balance sheet accounts using current exchange rates in effect at the balance sheet date and for income statement accounts using an average exchange rate during the period. Gains or losses resulting from such translation are included as a separate component of accumulated other comprehensive (loss)/income. Gains or losses resulting from foreign currency transactions are included in foreign currency income or loss except for the effect of exchange rates on long-term inter-company transactions considered to be a long-term investment, which is accumulated and credited or charged to other comprehensive income. Transaction gains and losses are recognized in our results of operations based on the difference between the foreign exchange rates on the transaction date and on the reporting date. The foreign currency exchange gains and losses are included as a component of general and administrative expenses in the accompanying Unaudited Condensed Consolidated Statements of Operations. The Company has recognized foreign exchanges gains and losses and changes in accumulated comprehensive income approximately as follows: For the Three Months Ended March 31, 2020 2019 Net foreign exchange transactions: Losses (gains) $ 584,000 $ (89,000 ) Accumulated comprehensive income: Unrealized (gains) losses on currency translation adjustment $ (277,000 ) $ 33,000 The exchange rates adopted for the foreign exchange transactions are the rates of exchange, as quoted on OANDA, a Canadian-based foreign exchange company and internet website providing currency conversion, online retail foreign exchange trading, online foreign currency transfers, and forex information. Translation of amounts from British Pounds into United States dollars was made at the following exchange rates for the respective periods: ● As of March 31, 2020 – British Pounds $1.237295 to US Dollars $1.00. ● The average rate for the three months ended March 31, 2020 – British Pounds $1.280500 to US Dollars $1.00.
Subsequent Events	Subsequent Events Management has evaluated subsequent events or transactions occurring through the date the consolidated financial statements were issued and determined that no events or transactions are required to be disclosed herein, except as disclosed.
Recently Issued Accounting Principles	Recently Issued Accounting Principles In June 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13 “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” which requires the measurement and recognition of expected credit losses for financial assets held at amortized cost. ASU 2016-13 replaces the existing incurred loss impairment model with an expected loss methodology. In November 2019, the FASB issued ASU No. 2019-10 to postpone the effective date of ASU No. 2016-13 for public business entities eligible to be smaller reporting companies defined by the SEC to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is currently evaluating the impact of this ASC on its consolidated financial statements. Other recent accounting standards issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC did not or are not believed by management to have a material impact on the Company’s present or future condensed consolidated financial statements.

Organization and Summary of S_3

Organization and Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Schedule of Anti-Ailutive Potential Common Stock Equivalents	The following table illustrates the anti-dilutive potential common stock equivalents excluded from the calculation of loss per share (in thousands): Three Months Ended March 31, 2020 2019 Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share: Stock options 391 610 Convertible debt — 1,352 Warrants 8,604 1,187 8,995 3,149
Schedule of Foreign Exchanges and Changes in Accumulated Comprehensive Income	The Company has recognized foreign exchanges gains and losses and changes in accumulated comprehensive income approximately as follows: For the Three Months Ended March 31, 2020 2019 Net foreign exchange transactions: Losses (gains) $ 584,000 $ (89,000 ) Accumulated comprehensive income: Unrealized (gains) losses on currency translation adjustment $ (277,000 ) $ 33,000

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	Intangible assets consist of the following finite assets: Patents and Licenses Trade Names and Customer Relationships Accumulated Accumulated Accumulated Costs Amortization Costs Amortization Costs Amortization Net Balance as of December 31, 2019 $ 12,378,000 $ (10,504,000 ) $ 1,450,000 $ (690,000 ) $ 2,880,000 $ (2,592,000 ) $ 2,922,000 Additions — — — — — — — Amortization — (167,000 ) — (56,000 ) — (78,000 ) (301,000 ) Balance as of March 31, 2020 $ 12,378,000 $ (10,671,000 ) $ 1,450,000 $ (746,000 ) $ 2,880,000 $ (2,670,000 ) $ 2,621,000
Schedule of Estimated Amortization Expense for Intangible Assets	The following table represents the estimated amortization expense for total intangible assets for the succeeding five years: Period ending March 31, 2021 $ 971,000 2022 871,000 2023 365,000 2024 119,000 2025 119,000 Thereafter 176,000 $ 2,621,000

Notes Payable (Tables)

Notes Payable (Tables)	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Schedule of Notes Payable	The table below represents the Company’s notes payable as of March 31, 2020, and December 31, 2019: Principal 3/31/20 12/31/19 Effective as of September 27, 2019, the Board of Directors of the Company consented to assume the remaining balance of a note held by a former related party MB Technology Holdings, LLC (“MBTH”). MBTH originally borrowed funds for the benefit of the Company with the proceeds forwarded to the Company reflecting due to a related party, ultimately converted into shares. The note matures on September 18, 2020, with an annual interest rate of 8.022%. One payment of $18,519 of accrued interest plus $230,860 of principal, totaling $249,379, is due on September 18, 2020. For the three months ended March 31, 2020, and 2019, interest expense is approximately $9,900 and $-0-, respectively. $ 231,000 $ 231,000 On October 2, 2019, the Company’s subsidiary, Integrated Microwave Technology (“IMT”), incurred a working capital loan of $150,000, with an annual interest rate of 1.9%, maturing on April 24, 2020. IMT has made $45,366 in principal and $15,424 in interest payments. 62,000 108,000 $ 293,000 $ 339,000

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Schedule of Operating Lease Data	The following table illustrates specific operating lease data for the three months ending March 31, 2020, and 2019: For the Three Months Ended March 31, 2020 2019 Lease cost: Operating lease cost $ 202,000 $ 301,000 Short-term lease cost 102,000 31,000 Variable lease cost — — Sublease income (46,000 ) (35,000 ) Total lease cost $ 258,000 $ 297,000 Cash paid for amounts in lease liabilities: Operating cash flows from operating leases $ 253,000 $ 310,000 Right-of-use assets obtained in exchange for new operating lease liabilities $ 546,000 $ 2,899,000 Weighted-average remaining lease term—operating leases 5.0 years 3.61 years Weighted-average discount rate—operating leases 9.4 % 9.2 %
Schedule of Future Minimum Rental Payments for Operating Leases	Maturities of our operating lease liabilities were as follows as of March 31, 2020: Amount 2021 $ 534,000 2022 395,000 2023 370,000 2024 356,000 2025 188,000 Total undiscounted operating lease payments 2,202,000 Less: amount representing an imputed interest 487,000 The present value of operating lease liabilities $ 1,715,000 Sublets: 2020 $ 51,000 2021 — $ 51,000
Schedule of Lease Obligations Assumed	The table below lists the location and lease expiration date from 2020 through 2026: Location Lease-End Date Approximate Future Payments Colchester, UK – Waterside House Mar 2025 $ 1,280,000 Hemel, UK. Oct 2020 101,000 Singapore Jul 2020 12,000 Anaheim, CA Jul 2021 41,000 Hackettstown, NJ Apr 2020 7,000 Sarasota, FL Sep 2022 86,000 Billerica, MA Dec 2026 675,000 Sublets: Hemel, UK. Oct 2020 $ 51,000

Related Party Transactions (Tab

Related Party Transactions (Tables)	3 Months Ended
	Mar. 31, 2020
Related Party Transactions [Abstract]
Schedule of Related Party Transactions	The following table represents a summary of related party transactions for the three months ended March 31, 2020, and 2019: For the three months ended March 31, 2020 2019 Consulting fees incurred, recurring $ 200,000 $ 150,000 Consulting fees incurred, non-recurring $ 120,000 $ 25,000 Common stock issued in satisfaction of amounts due: Quantity of shares issued — 8,159 Value of shares issued $ — $ 30,000 Amounts repaid to MBMG in cash $ *825,000 $ 230,000 *includes a final settlement in the amount of $230,000

Derivative Liabilities (Tables)

Derivative Liabilities (Tables)	3 Months Ended
	Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Valuation and Warrants Exercisable	The following are the critical assumptions used in connection with the valuation of the warrants exercisable into common stock as of March 31, 2020, and 2019: Three Months Ended March 31, 2020 2019 Number of shares underlying the warrants 462,428 492,815 Fair market value of stock $ 0.16 $ 3.50 Exercise price $ 0.0265 to $ 137.90 $ 4.50 to $ 137.90 Volatility 123% to 175 % 81% to 148 % Risk-free interest rate 0.17% to 0.29 % 2.21% to 2.27 % Expected dividend yield — — Warrant life (years) 1.1 to 3.2 0.8 to 4.2
Schedule of Changes in Fair Value of Level 3 Financial Liabilities	The following table sets forth a summary of the changes in the fair value of our Level 3 financial liabilities that are measured at fair value on a recurring basis: Three Months Ended March 31, 2020 2019 Beginning balance $ 30,000 $ 1,118,000 Recognition of warrant liabilities on issuance dates — — Re-classification to equity upon warrants exercised — Change in fair value of derivative liabilities (17,000 ) 74,000 Ending balance $ 13,000 $ 1,192,000

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
	Mar. 31, 2020
Schedule of Warrant Outstanding	The following table sets forth common stock purchase warrants outstanding as of March 31, 2020: Quantity of Warrants (in Weighted Average Exercise Price Outstanding, December 31, 2019 25,125,447 $ 1.10 Warrants granted 42,099,400 $ 0.20 Warrants exercised (56,127,764 ) $ (0.20 ) Warrants cancelled/expired (5,374 ) $ (411.80 00 ) Outstanding, March 31, 2020 11,094,709 $ 2.00 Exercisable, March 31, 2020 11,094,709 $ 2.00
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	Each option is estimated on the date of grant, using the Black-Scholes model and the following assumptions (all in weighted averages): For the three months ended March 31, 2020 2019 Exercise price $ -0- $ 0.89 Volatility 0 % 149.22 % Risk-free interest rate 0 % 2.68 % Expected dividend yield 0 % 0 % Expected term (years) 0 6
Schedule of Stock Option Activity	A summary of the status of the Company’s stock option plan for the period ended March 31, 2020, is as follows: Number of Options (in shares) Weighted Average Exercise Price Outstanding, December 31, 2019 505,050 $ 14.83 Options granted — $ — Options exercised — $ — Options canceled/expired (19,000 ) $ (14.98 ) Outstanding, March 31, 2020 486,050 $ 14.83 Exercisable, March 31, 2020 391,424 $ 15.42
Time Vested Option [Member]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	In determining the award’s grant-date fair value, the following assumptions were used (all in weighted averages): For the three months ended March 31, 2020 2019 Exercise price $ .285 $ — Volatility 153.02 % — Risk-free interest rate 1.57 % — Expected dividend yield 0 % — Expected term (years) 6.3 —
Schedule of Stock Option Activity	A summary of the status of the Company’s time vested stock option plan for the period ended March 31, 2020, is as follows: Number of Options (in shares) Weighted Average Exercise Price Outstanding, December 31, 2019 — $ — Options granted 2,155,481 $ .2745 Options exercised — $ — Options canceled/expired — $ Outstanding, March 31, 2020 2,155,481 $ .2662 Exercisable, March 31, 2020 — $ —
Performance-Based Option [Member]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	In determining the award’s grant-date fair value, the following assumptions were used (all in weighted averages): For the three months ended March 31, 2020 2019 Exercise price $ .285 $ — Volatility 153.02 % — Risk-free interest rate 1.57 % — Expected dividend yield 0 % — Expected term (years) 6.5 —
Schedule of Stock Option Activity	A summary of the status of the Company’s performance-based stock option plan for the period ended March 31, 2020, is as follows: Number of Options (in shares) Weighted Average Exercise Price Outstanding, December 31, 2019 — $ — Options granted 1,500,000 $ .2758 Options exercised — $ — Options canceled/expired — $ Outstanding, March 31, 2020 1,500,000 $ .2758 Exercisable, March 31, 2020 — $ —

Revenue (Tables)

Revenue (Tables)	3 Months Ended
	Mar. 31, 2020
Revenue from Contract with Customer [Abstract]
Schedule of Disggregation of Revenue	The Company has one operating segment, and the decision-making group is the senior executive management team. In the following table, revenue is disaggregated by primary geographical markets and revenue sources. Three Months Ended Three Months Ended March 31, 2020 March 31, 2019 Primary geographical markets: North America $ 2,076,000 $ 3,919,000 South America 21,000 19,000 Europe 1,963,000 2,350,000 Asia 105,000 1,390,000 Rest of World 1,187,000 528,000 $ 5,352,000 $ 8,206,000 Primary revenue source: Equipment sales $ 4,980,000 $ 7,561,000 Installation, integration and repairs 329,000 601,000 Warranties 43,000 44,000 $ 5,352,000 $ 8,206,000 Long-Lived Assets: United States $ 4,298,000 $ 6,119,000 United Kingdom 1,993,000 2,758,000 $ 6,291,000 $ 8,877,000

Subsequent Events (Tables)

Subsequent Events (Tables)	3 Months Ended
	Mar. 31, 2020
Subsequent Events [Abstract]
Schedule of Warrant Exercises and Common Stock Issued	Other events after March 31, 2020, to the date of this report Quantity of Warrants Exercised Quantity of Common Warrant Exercises: Cashless Warrants: Nov 2019 Equity Raise 20,000 15,000 Feb 2020 Equity Raise 9,547,836 7,160,877 9,567,836 7,175,877

Organization and Summary of S_4

Organization and Summary of Significant Accounting Policies (Details Narrative)	Jan. 31, 2020
Foreign exchange transaction rate	1
Foreign exchange transactions average rate	1
GBP [Member]
Foreign exchange transaction rate	1.237295
Foreign exchange transactions average rate	1.280500

Organization and Summary of S_5

Organization and Summary of Significant Accounting Policies - Schedule of Anti-Ailutive Potential Common Stock Equivalents (Details) - shares	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Antidilutive securities excluded from computation of earnings per share, amount	8,995,000	3,149,000
Stock Options [Member]
Antidilutive securities excluded from computation of earnings per share, amount	391,000	610,000
Convertible Debt [Member]
Antidilutive securities excluded from computation of earnings per share, amount		1,352,000
Warrants [Member]
Antidilutive securities excluded from computation of earnings per share, amount	8,604,000	1,187,000

Summary of Significant Accounti

Summary of Significant Accounting Policies - Schedule of Foreign Exchanges and Changes in Accumulated Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Accounting Policies [Abstract]
Net foreign exchange transactions: Losses (gains)	$ 584	$ (89)
Accumulated comprehensive income: Unrealized (gains) losses on currency translation adjustment	$ (277)	$ 33

Liquidity and Financial Condi_2

Liquidity and Financial Condition (Details Narrative) - USD ($)	May 13, 2020	Apr. 10, 2020	Mar. 27, 2020	Feb. 14, 2020	Nov. 27, 2019	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Loss from operations						$ (4,752,000)	$ (2,666,000)
Cash used in operating activities						(4,435,000)
Working capital						5,800,000
Accumulated deficit						(257,002,000)		$ (252,572,000)
Cash						$ 2,500,000
Common stock par value						$ 0.00001		$ 0.00001
Lease arrangement description						Entered into, effective May 1, 2020, a new lease arrangement at two new locations in Hackettstown, NJ, on a 90-day cycle for each site. Effectively lowing rental fees by approximately 81%. implemented proactive spending reductions in the first quarter of fiscal 2020 to improve liquidity, including a partial workforce reduction, the furlough of employees, reduced discretionary spending, resulting in approximately $5.0 million in annual savings.
Strategic Initiatives annual savings						$ 5,000,000
Debt instrument, maturity date						Apr. 5, 2022
Debt fixed rate						1.00%
Paycheck protection program description						Loan forgiveness is available for all or a portion of the PPP loan by the SBA or the associated lender. Upon an application by the Company following the protocols set forth under the CARES Act, loan forgiveness is available for the sum of documented payroll costs, covered rent payments, and covered utilities during the eight weeks beginning on the approval date of the PPP Loan. For purposes of the CARES Act, payroll costs exclude compensation of an individual employee more than $100,000, prorated annually. Not more than 25% of the forgiven amount may be for non-payroll expenses. There will be a reduction of the loan forgiveness if: the full-time headcount declines, or if salaries and wages for employees with salaries of $100,000 or less annually are reduced by more than 25%. Although the Company currently believes that its use of the PPP Loan will meet the conditions for the forgiveness of the loan, the Company cannot ensure that its PPP Loan will be forgiven, in whole or in part. The Company intends to use the proceeds for payroll costs, and costs used to continue group health care benefits, mortgage payments, rent, utilities, and interest on other debt obligations.
Paycheck Protection Program [Member]
Proceeds from loans			$ 1,200,000
Paycheck Protection Program [Member] | Subsequent Event [Member]
Proceeds from loans		$ 1,200,000
Debt instrument, maturity date		Apr. 5, 2022
Debt fixed rate		1.00%
Common Stock [Member]
Issuance of common stock shares				12,445,000	3,201,200
Warrants to purchase shares of common stock				11,120,400	11,320,725
Common stock par value				$ 0.00001
Proceeds from offering				$ 5,998,000	$ 3,988,096
Offering costs				560,000
Net proceeds from offering				$ 5,438,000
Pre-Funded Warrants [Member]
Issuance of common stock shares				14,827,200
Warrants to purchase shares of common stock				14,827,200	11,893,100
Common and Preferred Stock, Warrants [Member] | Subsequent Event [Member]
Proceeds from offering	$ 100,000,000
Warrants [Member]
Issuance of common stock shares				9,333,750
Warrants to purchase shares of common stock				9,333,750

Intangible Assets (Details Narr

Intangible Assets (Details Narrative) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Net of capitalized cost patent and licenses	$ 1,700		$ 1,900
Net of capitalized cost other intangible assets	$ 1,000		1,000
Amortized weighted average remaining life	3 years 7 months 6 days
Patents and Licenses [Member]
Amortization of intangible assets	$ 200		$ 200
Patents and Licenses [Member] | Minimum [Member]
Finite-lived intangible asset, useful life	18 years 6 months
Patents and Licenses [Member] | Maximum [Member]
Finite-lived intangible asset, useful life	20 years
Other Intangible Assets [Member]
Amortization of intangible assets	$ 100	$ 300
Other Intangible Assets [Member] | Minimum [Member]
Finite-lived intangible asset, useful life	3 years
Other Intangible Assets [Member] | Maximum [Member]
Finite-lived intangible asset, useful life	15 years

Intangible Assets - Schedule of

Intangible Assets - Schedule of Intangible Assets (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)
Beginning balance cost/ accumulated amortization	$ 2,922
Addition, cost/ accumulated amortization
Amortization, cost/ accumulated amortization	(301)
Ending balance, cost/ accumulated amortization	2,621
Patents and Licenses [Member]
Beginning balance cost	12,378
Intangible assets, Additions
Intangible assets, Amortization
Ending balance cost	12,378
Beginning balance, accumulated amortization	(10,504)
Intangible assets accumulated amortization, Additions
Intangible assets accumulated Amortization	(167)
Ending balance, accumulated Amortization	(10,671)
Trade Names and Technology [Member]
Beginning balance cost	1,450
Intangible assets, Additions
Intangible assets, Amortization
Ending balance cost	1,450
Beginning balance, accumulated amortization	(690)
Intangible assets accumulated amortization, Additions
Intangible assets accumulated Amortization	(56)
Ending balance, accumulated Amortization	(746)
Customer Relationships [Member]
Beginning balance cost	2,880
Intangible assets, Additions
Intangible assets, Amortization
Ending balance cost	2,880
Beginning balance, accumulated amortization	(2,592)
Intangible assets accumulated amortization, Additions
Intangible assets accumulated Amortization	(78)
Ending balance, accumulated Amortization	$ (2,670)

Intangible Assets - Schedule _2

Intangible Assets - Schedule of Estimated Amortization Expense for Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
2021	$ 971
2022	871
2023	365
2024	119
2025	119
Thereafter	176
Finite-Lived Intangible Assets, Net, Total	$ 2,621	$ 2,922

Notes Payable - Schedule of Not

Notes Payable - Schedule of Notes Payable (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Notes payable	$ 293	$ 339
MB Technology Holdings, LLC [Member]
Notes payable	231	231
Integrated Microwave Technology [Member]
Notes payable	$ 62	$ 108

Notes Payable - Schedule of N_2

Notes Payable - Schedule of Notes Payable (Details) (Parenthetical) - USD ($)	Oct. 02, 2019	Sep. 27, 2019	Mar. 31, 2020	Mar. 31, 2019
Debt instrument maturity date			Apr. 5, 2022
Debt instrument stated interest rate percentage			1.00%
MB Technology Holdings, LLC [Member]
Debt instrument maturity date		Sep. 18, 2020
Debt instrument stated interest rate percentage		8.022%
Debt accrued interest		$ 18,519
Debt principal payment		230,860
Debt payment		$ 249,379
Interest expense			$ 9,900	$ 0
Integrated Microwave Technology [Member]
Debt instrument maturity date	Apr. 24, 2020
Debt instrument stated interest rate percentage	1.90%
Debt accrued interest	$ 15,424
Debt principal payment	45,366
Working capital loan	$ 150,000

Leases (Details Narrative)

Leases (Details Narrative) $ in Thousands	Jan. 24, 2020USD ($)ft²	Mar. 31, 2020USD ($)	Mar. 31, 2019USD ($)	Dec. 31, 2019USD ($)
Weighted average remaining term for lease minimum		3 months
Weighted average remaining term for lease maximum		4 years 9 months 18 days
Right of use of assets		$ 1,782		$ 1,925
Operating lease liabilities		2,370
Gain on termination of lease		(21)
Lease liabilities, current		$ 383		$ 821
Lease maturity date, description		Maturity dates ranging from April 2020 to December 2026.
Weighted average discount rate, percentage		9.40%
Operating lease rental fees		$ 258	297
Rent income		$ 46	$ 35
New Lease Agreement [Member]
Area of land | ft²	39,237
Lease expiration date	Dec. 31, 2026
Right of use of assets	$ 533
Operating lease liabilities	904
Accumulated amortization of operating lease	$ 371

Leases - Schedule of Operating

Leases - Schedule of Operating Lease Data (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Commitments and Contingencies Disclosure [Abstract]
Operating lease cost	$ 202	$ 301
Short-term lease cost	102	31
Variable lease cost
Sublease income	(46)	(35)
Total lease cost	258	297
Operating cash flows from operating leases	253	310
Right-of-use assets obtained in exchange for new operating lease liabilities	$ 546	$ 2,889
Weighted-average remaining lease term-operating leases	5 years	3 years 7 months 10 days
Weighted-average discount rate-operating leases	9.40%	9.20%

Leases - Schedule of Future Min

Leases - Schedule of Future Minimum Rental Payments for Operating Leases (Details) $ in Thousands	Mar. 31, 2020USD ($)
2021	$ 534
2022	395
2023	370
2024	356
2025	188
Total undiscounted operating lease payments	2,202
Less: amount representing an imputed interest	487
The present value of operating lease liabilities	1,715
Sublets [Member]
2020	51
2021
Total undiscounted operating lease payments	$ 51

Leases - Schedule of Lease Obli

Leases - Schedule of Lease Obligations Assumed (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)
Approximate Future Payments	$ 2,202
Sublets [Member]
Approximate Future Payments	$ 51
Colchester, U.K. - Waterside House [Member]
Lease-End Date	May 31, 2025
Approximate Future Payments	$ 1,280
Hemel, U.K [Member]
Lease-End Date	Oct. 31, 2020
Approximate Future Payments	$ 101
Hemel, U.K [Member] | Sublets [Member]
Lease-End Date	Oct. 31, 2020
Approximate Future Payments	$ 51
Singapore [Member]
Lease-End Date	Jul. 31, 2020
Approximate Future Payments	$ 12
Anaheim, CA [Member]
Lease-End Date	Jul. 31, 2021
Approximate Future Payments	$ 41
Hackettstown, NJ [Member]
Lease-End Date	Apr. 30, 2020
Approximate Future Payments	$ 7
Sarasota, FL [Member]
Lease-End Date	Sep. 30, 2022
Approximate Future Payments	$ 86
Billerica, MA [Member]
Lease-End Date	Dec. 31, 2026
Approximate Future Payments	$ 675

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($) $ in Thousands	Feb. 25, 2020	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Gain on settlement of related party obligations		$ 331
MB Merchant Group, LLC [Member]
Gain on settlement of related party obligations	$ 561	331
Related party transaction remitting amount	$ 230
Due to related parties		$ 0		$ 505

Related Party Transactions - Sc

Related Party Transactions - Schedule of Related Party Transactions (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020		Mar. 31, 2019
Common stock shares issued in satisfaction of amounts due: Value of shares issued			$ 66
MB Merchant Group, LLC [Member] | MBMG Agreement [Member]
Consulting fees incurred, recurring	$ 200		150
Consulting fees incurred, non-recurring	$ 120		$ 25
Common stock shares issued in satisfaction of amounts due: Quantity of shares issued			8,159
Common stock shares issued in satisfaction of amounts due: Value of shares issued			$ 30
Amounts repaid to MBMG in cash	$ 825	[1]	$ 230
[1]	includes a final settlement in the amount of $230,000

Related Party Transactions - _2

Related Party Transactions - Schedule of Related Party Transactions (Details) (Parenthetical) $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)
MB Merchant Group, LLC [Member] | MBMG Agreement [Member]
Related party settlement amount	$ 230

Derivative Liabilities - Schedu

Derivative Liabilities - Schedule of Valuation and Warrants Exercisable (Details)	3 Months Ended
	Mar. 31, 2020$ / sharesshares	Mar. 31, 2019$ / sharesshares
Number of shares underlying the warrants | shares	462,428	492,815
Minimum [Member]
Warrant life (years)	1 year 1 month 6 days	9 months 18 days
Maximum [Member]
Warrant life (years)	3 years 2 months 12 days	4 years 2 months 12 days
Fair Market Value of Stock [Member]
Warrants exercise price	$ 0.16	$ 3.50
Exercise Price [Member] | Minimum [Member]
Warrants exercise price	0.0265	4.50
Exercise Price [Member] | Maximum [Member]
Warrants exercise price	$ 137.90	$ 137.90
Expected Volatility [Member] | Minimum [Member]
Warrants and rights outstanding, measurement input	123	81
Expected Volatility [Member] | Maximum [Member]
Warrants and rights outstanding, measurement input	175	148
Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member]
Warrants and rights outstanding, measurement input	0.17	2.21
Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member]
Warrants and rights outstanding, measurement input	0.29	2.27
Measurement Input, Expected Dividend Rate [Member]
Warrants and rights outstanding, measurement input	0	0

Derivative Liabilities - Sche_2

Derivative Liabilities - Schedule of Changes in Fair Value of Level 3 Financial Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Beginning balance	$ 30	$ 1,118
Recognition of warrant liabilities on issuance dates
Re-classification to equity upon warrants exercised
Change in fair value of derivative liabilities	(17)	74
Ending balance	$ 13	$ 1,192

Stockholders' Equity (Details N

Stockholders' Equity (Details Narrative) - USD ($)	Feb. 14, 2020	Jan. 22, 2020	Nov. 27, 2019	Mar. 31, 2020	Mar. 31, 2019
Number of warrants, granted				42,099,400
Number of warrants, exercised				(56,127,764)
Number of warrants, cancelled/expired				(5,374)
Common Stock [Member]
Issuance of common stock shares	12,445,000		3,201,200
Warrants to purchase shares of common stock	11,120,400		11,320,725
Net proceeds from offering cost	$ 5,998,000		$ 3,988,096
Proceeds from issuance of offering	$ 5,286,000
Pre Funded Warrants [Member]
Issuance of common stock shares	14,827,200
Warrants to purchase shares of common stock	14,827,200		11,893,100
Offering cost	$ 712,000
Warrants [Member]
Issuance of common stock shares	9,333,750
Warrants to purchase shares of common stock	9,333,750
Public Warrants [Member]
Issuance of common stock shares	47,088,398
Warrants to purchase shares of common stock	56,127,764
Proceeds from issuance of offering	$ 9,600
Common Stock Warrants [Member]
Number of warrants, granted				42,099,400
Number of warrants, exercised				56,127,764
Number of warrants, cancelled/expired				5,374
Warrant exercise price per share				$ 2
Warrants weighted average remaining contractual life				1 year
Outstanding warrants intrinsic value
Common Stock Options [Member]
Stock compensation expense				$ 386,000	$ 609,000
Weighted average remaining contractual life of option				7 years 2 months 30 days
Weighted average remaining contractual life of option exercisable				7 years 1 month 16 days
Intrinsic value of options exercisable
Remaining stock compensation expense				$ 260,000
Amortization period				1 year 2 months 12 days
Weighted average fair value of options granted				$ 0	$ 0.89
Time Vested Option [Member]
Stock compensation expense				$ 18,000	$ 0
Weighted average remaining contractual life of option exercisable				9 years 9 months 25 days
Intrinsic value of options exercisable				$ 0
Remaining stock compensation expense				$ 574,000
Amortization period				3 years 9 months 22 days
Weighted average fair value of options granted				$ 0.275	$ 0
Time Vested Option [Member] | CEO's Employment Agreement [Member]
Options to purchase common stock for award		2,155,481
Exercise price of shares purchased for award		$ 0.285
Options vesting commencement date		Jan. 22, 2020
Options vesting expiration date		Jan. 22, 2030
Options vesting percentage		75.00%
Vesting rights description		The options vest as follows: 25% of the Option Shares shall vest on the first anniversary of the Vesting Commencement Date; and, the remaining 75% will vest in substantially equal monthly installments over the thirty-six (36) month period following the first anniversary of the Vesting Commencement Date.
Performance-Based Option [Member]
Weighted average remaining contractual life of option exercisable				9 years 9 months 25 days
Intrinsic value of options exercisable				$ 0
Weighted average fair value of options granted				$ 0.276	$ 0
Unrecognized stock-based compensation expense				$ 414,000
Performance-Based Option [Member] | Tranche One [Member]
Vesting rights description		Tranche 1: 500,000 Option Shares will vest upon the Company's attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $6,000,000 accumulated over four consecutive fiscal quarters.
Number of options expected to vest		500,000
Performance-Based Option [Member] | Tranche Two [Member]
Vesting rights description		Tranche 2: 500,000 Option Shares will vest upon the Company's attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $15,000,000 accumulated over four consecutive fiscal quarters.
Number of options expected to vest		500,000
Performance-Based Option [Member] | Tranche Three [Member]
Vesting rights description		Tranche 3: 500,000 Option Shares will vest upon the Company's attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $23,000,000 accumulated over four consecutive fiscal quarters.
Number of options expected to vest		500,000
Performance-Based Option [Member] | CEO's Employment Agreement [Member]
Options to purchase common stock for award		1,500,000
Exercise price of shares purchased for award		$ 0.285
Options vesting commencement date		Jan. 22, 2020
Options vesting expiration date		Jan. 22, 2030

Stockholders' Equity - Schedule

Stockholders' Equity - Schedule of Warrant Outstanding (Details)	3 Months Ended
	Mar. 31, 2020$ / sharesshares
Equity [Abstract]
Number of warrants, Beginning Balance | shares	25,125,447
Number of warrants, granted | shares	42,099,400
Number of warrants, exercised | shares	(56,127,764)
Number of warrants, cancelled/expired | shares	(5,374)
Number of warrants, Ending outstanding | shares	11,094,709
Weighted Average Exercise Price, Beginning Balance	$ 1.10
Weighted Average Exercise Price, granted	0.20
Weighted Average Exercise Price, exercised	(0.20)
Weighted Average Exercise Price, cancelled/expired	(411.8000)
Weighted Average Exercise Price, Ending outstanding	2
Weighted Average Exercise Price, Ending exercisable	$ 2

Stockholders' Equity - Schedu_2

Stockholders' Equity - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details) - $ / shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Common Stock Options [Member]
Exercise price	$ 0	$ 0.89
Volatility	0.00%	149.22%
Risk-free interest rate	0.00%	2.68%
Expected dividend yield	0.00%	0.00%
Expected term (years)	0 years	6 years
Time Vested Option [Member]
Exercise price	$ 0.285	$ 0
Volatility	153.02%	0.00%
Risk-free interest rate	1.57%	0.00%
Expected dividend yield	0.00%	0.00%
Expected term (years)	6 years 3 months 19 days	0 years
Performance-Based Option [Member]
Exercise price	$ 0.285	$ 0
Volatility	153.02%	0.00%
Risk-free interest rate	1.57%	0.00%
Expected dividend yield	0.00%	0.00%
Expected term (years)	6 years 3 months 19 days	0 years

Stockholders' Equity - Schedu_3

Stockholders' Equity - Schedule of Stock Option Activity (Details)	3 Months Ended
	Mar. 31, 2020$ / sharesshares
Common Stock Options [Member]
Number of Options, Beginning Balance | shares	505,050
Number of Options, granted | shares
Number of Options, exercised | shares
Number of Options, cancelled/expired | shares	(19,000)
Number of Options, Ending Outstanding | shares	486,050
Number of Options Exercisable | shares	391,424
Weighted Average Exercise Price, Outstanding Beginning Balance | $ / shares	$ 14.83
Weighted Average Exercise Price, granted | $ / shares
Weighted Average Exercise Price, exercised | $ / shares
Weighted Average Exercise Price, cancelled/expired | $ / shares	(14.98)
Weighted Average Exercise Price, Outstanding Ending Balance | $ / shares	14.83
Weighted Average Exercise Price, Exercisable Balance | $ / shares	$ 15.42
Time Vested Option [Member]
Number of Options, Beginning Balance | shares
Number of Options, granted | shares	2,155,481
Number of Options, exercised | shares
Number of Options, cancelled/expired | shares
Number of Options, Ending Outstanding | shares	2,155,481
Number of Options Exercisable | shares
Weighted Average Exercise Price, Outstanding Beginning Balance | $ / shares
Weighted Average Exercise Price, granted | $ / shares	.2745
Weighted Average Exercise Price, exercised | $ / shares
Weighted Average Exercise Price, cancelled/expired | $ / shares
Weighted Average Exercise Price, Outstanding Ending Balance | $ / shares	.2662
Weighted Average Exercise Price, Exercisable Balance | $ / shares
Performance-Based Option [Member]
Number of Options, Beginning Balance | shares
Number of Options, granted | shares	1,500,000
Number of Options, exercised | shares
Number of Options, cancelled/expired | shares
Number of Options, Ending Outstanding | shares	1,500,000
Number of Options Exercisable | shares
Weighted Average Exercise Price, Outstanding Beginning Balance | $ / shares
Weighted Average Exercise Price, granted | $ / shares	.2758
Weighted Average Exercise Price, exercised | $ / shares
Weighted Average Exercise Price, cancelled/expired | $ / shares
Weighted Average Exercise Price, Outstanding Ending Balance | $ / shares	.2758
Weighted Average Exercise Price, Exercisable Balance | $ / shares

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands	Feb. 14, 2020	Nov. 27, 2019	Jul. 29, 2019	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Sep. 26, 2019
Common stock par value				$ 0.00001		$ 0.00001
Common Stock [Member]
Issuance of common stock shares	12,445,000	3,201,200
Common stock par value	$ 0.00001
Warrants to purchase shares of common stock	11,120,400	11,320,725
Offering percentage	20.00%
Pre Funded Warrants [Member]
Issuance of common stock shares	14,827,200
Warrants to purchase shares of common stock	14,827,200	11,893,100
Hale Capital Partners, LP [Member]
Due diligence transaction amount			$ 140
Contributions by employer amount				$ 43	$ 33
Nasdaq Stock Market LLC [Member] | Minimum [Member]
Closing bid price							$ 1

Concentrations (Details Narrati

Concentrations (Details Narrative) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Revenue	$ 5,352	$ 8,206
Accounts payable	$ 4,390		$ 6,784
Sales Revenue, Net [Member] | Single Customer [Member]
Concentration risk percentage	16.00%	10.00%
Revenue	$ 854
Accounts Receivable [Member] | Single Customer [Member]
Concentration risk percentage	15.00%
Accounts receivable	$ 605
Accounts Receivable [Member] | One Customer [Member]
Concentration risk percentage		12.00%
Accounts receivable		$ 649
Purchases [Member] | One Vendor [Member]
Concentration risk percentage	36.00%	43.00%
Revenue	$ 1,084	$ 2,467
Accounts Payable [Member] | One Vendor [Member]
Concentration risk percentage	15.00%
Accounts Payable [Member] | Vendor One [Member]
Concentration risk percentage	11.00%
Accounts payable	$ 634
Accounts Payable [Member] | Vendor Two [Member]
Concentration risk percentage	11.00%
Accounts payable	$ 494
Accounts Payable [Member] | Vendor Three [Member]
Accounts payable	$ 459
Accounts Payable [Member] | Single Vendor [Member]
Concentration risk percentage		10.00%

Revenue - Schedule of Disggrega

Revenue - Schedule of Disggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenue, net	$ 5,352	$ 8,206
Long-Lived Assets	6,291	8,877
Equipment Sales [Member]
Revenue, net	4,980	7,561
Installation, Integration and Repairs [Member]
Revenue, net	329	601
Warranties [Member]
Revenue, net	43	44
North America [Member]
Revenue, net	2,076	3,919
South America [Member]
Revenue, net	21	19
Europe [Member]
Revenue, net	1,963	2,350
Asia [Member]
Revenue, net	105	1,390
Rest of World [Member]
Revenue, net	1,187	528
United States [Member]
Long-Lived Assets	4,298	6,119
United Kingdom [Member]
Long-Lived Assets	$ 1,993	$ 2,758

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	Apr. 10, 2020	Mar. 27, 2020	Mar. 31, 2020
Debt instrument, maturity date			Apr. 5, 2022
Debt fixed rate			1.00%
Paycheck Protection Program [Member]
Proceeds from loans		$ 1,200,000
Subsequent Event [Member] | Paycheck Protection Program [Member]
Proceeds from loans	$ 1,200,000
Debt instrument, maturity date	Apr. 5, 2022
Debt fixed rate	1.00%

Subsequent Events - Schedule of

Subsequent Events - Schedule of Warrant Exercises and Common Stock Issued (Details) - shares	May 21, 2020	Dec. 31, 2019
Quantity of Common Stock Issued		21,567,287
Subsequent Event [Member]
Quantity of Warrants Exercised	9,567,836
Quantity of Common Stock Issued	7,175,877
Subsequent Event [Member] | Nov 2019 Equity Raise [Member]
Quantity of Warrants Exercised	20,000
Quantity of Common Stock Issued	15,000
Subsequent Event [Member] | Feb 2020 Equity Raise [Member]
Quantity of Warrants Exercised	9,547,836
Quantity of Common Stock Issued	7,160,877